%PDF-1.3
1 0 obj
<<
/CreationDate(D:20190614101652)
/Title()
/Producer(Synactis PDF In-The-Box version 2.2)
>>
endobj
5 0 obj
[
750 750 278 255 352 555 555 885 668 188 330 330 390 585 278 330 
278 278 555 555 555 555 555 555 555 555 555 555 278 278 585 585 
585 555 1012 668 668 720 720 668 608 772 720 278 502 668 555 832 
720 772 668 772 720 668 608 720 668 945 668 652 608 278 278 278 
458 555 330 555 555 502 555 555 278 555 555 225 225 502 225 832 
555 555 555 555 330 502 278 555 502 712 495 488 502 330 255 330 
585 750 555 750 225 555 330 998 555 555 330 998 668 330 998 750 
608 750 750 225 225 330 330 352 555 998 345 998 502 330 945 750 
502 668 278 322 555 555 555 555 255 555 330 735 368 555 585 330 
735 548 398 548 330 330 330 578 532 330 330 330 368 555 832 832 
832 608 668 668 668 668 668 668 998 720 668 668 668 668 278 278 
278 278 720 720 772 772 772 772 772 585 772 720 720 720 720 668 
668 608 555 555 555 555 555 555 885 502 555 555 555 555 278 278 
278 278 555 555 555 555 555 555 555 548 608 555 555 555 555 502 
]
endobj
6 0 obj
<<
/Type/FontDescriptor
/FontName/Arial
/Ascent 892
/Descent -225
/ItalicAngle 0
/CapHeight 892
/Flags 32
/FontBBox[0 0 0 0]
>>
endobj
7 0 obj
<<
/Type/Font
/Subtype/TrueType
/Name/F0
/BaseFont/Arial
/Encoding/WinAnsiEncoding
/FirstChar 30
/LastChar 255
/Widths 5 0 R
/FontDescriptor 6 0 R
>>
endobj
8 0 obj
[
750 750 278 308 472 555 555 862 720 240 330 330 390 585 278 330 
278 278 555 555 555 555 555 555 555 555 555 555 330 330 585 585 
585 608 975 690 720 720 720 668 608 772 720 278 555 720 608 832 
720 772 668 772 720 668 608 720 668 945 668 668 608 330 278 330 
585 555 330 555 608 555 608 555 330 608 608 278 278 555 278 885 
608 608 608 608 390 555 330 608 532 802 555 532 502 390 278 390 
585 750 555 750 278 555 502 998 555 555 330 1005 668 330 998 750 
608 750 750 278 278 502 502 352 555 998 330 998 555 330 945 750 
502 668 278 338 555 555 555 555 278 555 330 735 368 555 585 330 
735 548 398 548 330 330 330 578 555 330 330 330 368 555 832 832 
832 608 720 720 720 720 720 720 998 720 668 668 668 668 278 278 
278 278 720 720 772 772 772 772 772 585 772 720 720 720 720 668 
668 608 555 555 555 555 555 555 885 555 555 555 555 555 278 278 
278 278 608 608 608 608 608 608 608 548 608 608 608 608 608 555 
]
endobj
9 0 obj
<<
/Type/FontDescriptor
/FontName/Arial
/Ascent 922
/Descent -225
/ItalicAngle 0
/CapHeight 922
/Flags 32
/FontBBox[0 0 0 0]
>>
endobj
10 0 obj
<<
/Type/Font
/Subtype/TrueType
/Name/F1
/BaseFont/Arial,Bold
/Encoding/WinAnsiEncoding
/FirstChar 30
/LastChar 255
/Widths 8 0 R
/FontDescriptor 9 0 R
>>
endobj
11 0 obj
<<
/Length 1142
>>
stream
1 1 1 rg
315.496 675.496 79.37 28.913 re f
BT
/F0 10 Tf
0 0 0 rg
316.63 694.351 Td
(Paciente:) Tj
ET
1 1 1 rg
396.567 675.496 167.244 28.913 re f
BT
/F1 12 Tf
0 0 0 rg
397.701 692.206 Td
(Dña. MARIA BELIO BERGUA) Tj
ET
1 1 1 rg
315.496 647.433 79.37 26.362 re f
BT
/F0 10 Tf
0 0 0 rg
316.63 663.736 Td
(Dr./Dra.:) Tj
ET
1 1 1 rg
396.567 647.433 167.244 26.362 re f
BT
/F1 10 Tf
0 0 0 rg
397.701 663.436 Td
(HAMADACHE) Tj
ET
1 1 1 rg
315.496 619.37 79.37 26.362 re f
BT
/F0 10 Tf
0 0 0 rg
316.63 635.673 Td
(Análisis:) Tj
ET
1 1 1 rg
396.567 619.37 167.244 26.362 re f
BT
/F1 10 Tf
0 0 0 rg
397.701 635.373 Td
(4580) Tj
ET
1 1 1 rg
315.496 591.307 79.37 26.362 re f
BT
/F0 10 Tf
0 0 0 rg
316.63 607.61 Td
(Fecha registro:) Tj
ET
1 1 1 rg
396.567 591.307 167.244 26.362 re f
BT
/F1 10 Tf
0 0 0 rg
397.701 607.31 Td
(11/Jun/2019) Tj
ET
1 1 1 rg
315.496 563.244 79.37 26.362 re f
BT
/F0 10 Tf
0 0 0 rg
316.63 579.547 Td
(Fecha impresión:) Tj
ET
1 1 1 rg
396.567 563.244 167.244 26.362 re f
BT
/F1 10 Tf
0 0 0 rg
397.701 579.247 Td
(14/Jun/2019) Tj
ET
q
198.709 0 0 85.039 0.283 756.567 cm
/Im0 Do
Q
q
204.378 0 0 50.457 193.89 0.283 cm
/Im1 Do
Q
endstream
endobj
12 0 obj
<<
/Type/XObject
/Subtype/Image
/Width 588
/Height 252
/ColorSpace/DeviceRGB
/BitsPerComponent 8
/Length 20036
/Filter[/ASCII85Decode/DCTDecode]
>>
stream
s4IA0!"_al8O`[\!<<*#!!*'"s4[N@!!<9(!s/N+!s8W.!s8Z0#R(A7"9f,;#6kGB$4I=N$4@4N%MB<^%M90Y$P4'b&JGin'bq,f(Dmo%(_RMt'`Znf6NI8l"9eo3#mCJ='FbEZ'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GUS_!"fJ:quTOo!?qLF&HMtG!WU(<*rl9A"T\W)!<E3$z!!!!"!WrQ/"pYD?$4HmP!4<@<!W`B*!X&T/"U"r.!!.KK!WrE*&Hrdj0gQ!W;.0\RE>10ZOeE%*6F"?A;UOtZ1LbBV#mqFa(`=5<-7:2j.Ps"@2`NfY6UX@47n?3D;cHat='/U/@q9._B4u!oF*)PJGBeCZK7nr5LPUeEP*;,qQC!u,R\HRQV5C/hWN*81['d?O\@K2f_o0O6a2lBFdaQ^rf%8R-g>V&OjQ5OekiqC&o(2MHp@n@XqZ"J6*ru?D!<E3%!<E3%!<<*"!!!!"!WrQ/"pYD?$4HmP!4<C=!W`?*"9Sc3"U"r.!<RHF!<N?8"9fr'"qj4!#@VTc+u4]T'LIqUZ,$_k1K*]W@WKj'(*k`q-1Mcg)&ahL-n-W'2E*TU3^Z;(7Rp!@8lJ\h<``C+>%;)SAnPdkC3+K>G'A1VH@gd&KnbA=M2II[Pa.Q$R$jD;USO``Vl6SpZEppG[^WcW]#)A'`Q#s>ai`&\eCE.%f\,!<j5f=akNM0qo(2MHp@n@XqZ#7L$j-M1!YGMH!'^J^;kf-t!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?eOsDcg]*(P?An->rWAFV?q+'K&r"MZ:57-aq1k,u`n]-H\(hBqC;T]49H266Ffg+6TODF!^gILu%^\EM2J)HrS\r5598g<b2lIN*@R[FCr"E8fl3QE,RH/RWY=ipf=R':l$4L.^;3&neU4\3VqIHF\Mb&LFdST^(irrADFGSmO&Q+0]grrC.:43.@$n5)?/*]TU1\+'l5(UIqC[*\3+&ch0Q+*>1V,W7Y&E\ZYL?Q=M?hcr"EHpdF0`5T's9lB$a9Q;6R_=[o]^6eea5N&,:LW+*Kf>Sdp\@M,'L2N)GBr9X`>KaBb(m($e@RGZ9"L'8H+J619&(p('^P=C)c#<+?7_)D$kL:\7DFj6-;T+#$+-<Zm^1imEo(H%^VUkH6nU5m#Set^5+`kq0^N]MrP$/sp)t?kEcB;o!&c>Q6qnb?NBkE<E]ht0#A(5T@:2AYa)?0]Q9E$C86?lGIa^O4h3"MEpi_(em\-*P8-/4r6A7C$.T=92^qZ_E_nXL5QpdGC@FP4XiM/r=9)(.ENP9+ej8fu5#^(L=?rr?H!'mpFp\a]lXE;hKZPX*>AnO'VEce_du&6B^lY8eO8i"D&3.a6eUWD+`:V>)qJ!!#rkMo)WAb3R7KO3fP1J$oU"hqAAPdn%t-9(<HudV*ru,Im![N9>#PrR7A!$MO>o!q96QWVD+c3ZaQ[b0au`2mD%?9+6Lq3F.bIeWf078)>7?:E3m=]0WZj9$o1@Y&>Z:/hQ!PUq3(K,g6r(lp)F9WNV]7ZJ&H/j6WV<YG9p'^cbp4.X6c`Fgk9I'N&3oH=95V:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!"?M7F/[()N.k!Wh^ir]\<l/$qA;-t/b,PI]'mI;e:ah0:bmga*;=iodLkldq"La>@EF?`RL\$*P\hhthOZ$#+,!/:cJ>.2O*o]%2fR;<;Gku0_F"H8r42<qi_\sF_p2f<2V\A;4(=4Z5`ehgGMnB9g`L]/lMD)Iprh7W5pfea>=fra0/OsnT]p*=.<Oj/%ak/oH4S7J_KZ>$A4U5CE)(%E[L'U/6IS&&DI[eO^5>dR\S^B^7,b8ZPj=mjug(cgCsA/p(+O?j=_CWe3^`q%:2@Sg3ua9mG-8NrYGiFg3GM&/Am^+]8V`DW"b4[S\ih&0#1!\d/Eo>(g=E-l]i(%iP2K34X>[%G5FIXOH)o!98&PqH2-0?^?Xr5dR5AijrNP&_'r13--2SiUtsVE\I\g$TB2*u2Pt22bJEn?7V!?JWObB]keueNuP@8hj5^!RYk4jF#6T'>[MC4YSp[ES)AE]QEf3MZ%l$!.oHC4cdD9Z[S7>8IEG8G`(Kd;Ka8gQ&`q2^uNU+39U_iGH\F"nT)KT)hYMoUA=9Q>k%5><GKW=QD`2FWtGS9$ApM=NWA\QSOF:h&b[ABFBPALFUj?ab/5?SfSXec!V,o7^LB8XL]7@^oD$L'[L;$*CIpB6(^V-uYGBBS&3HnkOhp&YOE+DMll%:T]M9rZ.E5@ng.?_41oWg!C(#6)U5JcEp<!99/AGh)%`bDZiX>2ol:JS<h>']'aiE*\;99^606<ZQ#W%7ReAYEeW@PDW8s,qd3P?$i?Pkskp_VjhPV7DoY/@/"K.pFUmk1b(nrYRba<P]ANoX9]^,u>pK!)^k4<=gu-ntc]h.tUf]B;-p6oi:_^1"4,4>YpAM-mXi!0=:c2#C!;`VTPWM_3cOXo#V`XHGNa)Y.jX$\ZC#h%fCEhsa97MXtP_/@t;(@(@C%ZUoF_a6qsr_@-K-!Kk^b`I5unY:RIl@qmATfDQK"H/Qj\MSs9s2FF8>!.q1t<\jgV+7NBcStBQ)":X=og3W`<f;O'[rr@YPg"]h$Dr[Glc)77EYC3/#)1nG9qjA0p)<?Q;9)0RgfBf'u8)V(npYI(_c,]NOH^V994kAWC5pQoa+"0,Ok6of/CWH3d35G`K]7;SS7jF\PH\6n%$MIM#Q=Ag!E(tP7rr=GBS6oL>;3ds7boaV@%6c@g9B-5/rNY;jC>W4"(g.7p&jkYlA<F;A2TKD3X\nlRiXZk#9Asd%Y';;J:VGBPfF?VZHB]%:*:]p^-j_(Um=C)03?oA$YJfma^Ctudn:S\<hBDBsV_477gPcd__G;$PP`^7JLH+&GJhY#8I_u*-J$cYFqal#OqaTCB_o*<P@b!<KgPdm"_l:H,NIjImK?,q?\W0N<Z:_bmqKM9$5:>7[Yh7K`:(ku^f#PYjrX,.bE"]q<4q$4.YP*,&+HF5-p%A6D[XHKq5lJChmu>'qAFPA6o_fFsReGOYV9>[N4Bpo@Q\kX^,fqM,$tB<B3QSCe5Afk?$h-C@7Jo%Zr^V]#_=mgb:]QW430Gn=q+4rp4U=(1]Ka:t-,&f'LpYub9:]oW4Z_[WXefC_F?>a`4QPZTh,i4%qVUYP"uck764%]b+(tTR&%Ua!CCrnB/EGWYVt:?cE8LkK-gAA`IMca)0@O'OSO1scLo56M;8e=?Or+e[[<FM(ADo"YE0@OtejZPa-*msVkP37#!!OtENe?k#>gWBNV>+h,cn+TRV7"S8Xi86-YWElAMKK(qK=;0t$MDYl)uF](EF4=T"7Ka+SRCt']GjVpPogMR/,SR4U%o8X&]eTY=2TOW:N(fdnQY$7G_8nFVpN(+bC(U-%`rUK6jbp7N,R#Ij;H6gqRij669&_Ils+HDZ@.5#UA:BU0"g"Bd%p$brrC[1I\hEP](%B8Jb2U-(o;m,-+LBdDd_%'Gi4HK)n`Qgmb]GNP'J1A3`h4<g4-LGU&-`m5=Ci([aX\-8ZQ-aiJ1Bhjb7).qo:3,LtTru3QGId(%cp'4FZ0p(.Z=#g)jA)[\(jn]KWBl>8@%IOgdr/m5^E8cV:DqS.'CJpdjH8T)/1]gKcrOZ*g/ENfR88hWb%?n5UQf.B(t/UZ'N)]nho$U+:"0[@*+7*Dr9dW-i^.+<5%B^J=DQDUZO-/V^<9.aMaS$;V(mS\^SA+G9I@oBlVa.LEo9!Bi0-F<BlO:TrbB=b#A!rr<e[O+%4%iTlnt9gceHI>!2<-J<r`Du^^T&tRA:c>24]o#`d;7^a?X[X.lO!3a?!bOJN12[YT>f_WaJ/*AS>-c\D(nJB+a#N632g[FK7B32K"g:"Ya]nMPW^EEi&\KL_jR;c5I@I[;F](=uXh-5:?l?fk0,.[>_(%Tq`q]b?t"4PSQ4s#)?nPm4\YodZMot01&CT.kh4Am;!_f>rQm@Jc8c@4)g0\5pSfc/pO[A`!=[\s\6,#%_@mfE!;.#l?i$;VL$&WpA6;M:b2.9*mi>?U:g)1,D\b:),Ep-f_d8&5_hQX0C<n@(^R0>nrgr[q>kX^aD/Ss+UH97(V3N;M#3]62q[:3eF]f;S\m4s]Y>PN#@ZHo1@oX#@_8i>[SVdoa6^!*_U^W_@kMaX)IDV">n69l(e`WUa"dE8=[k[[m's<H>M-AG/0e`d7U8L:en7lF&`b`jL)+DXq#rp1Rc:M$FB<%o\L8%/O$Sn0>bU,k-S@Q;8?5\(^#%of3KSpY'MV=D_@>nfUsY+s8k^i"?@gY6XRJPN&e#0>tHq[t!D^A&;R]2!`bude(co?aJ"U'L+F[aiN`P"<L;<)fj^Em5a)H*<+2H$Y8b1NV36G^q.4tE60/pGg1H0>QPd:Ej!m!^i=l)j5pfeY.Aj7rrC_8U/R7WdJ_\cjki_!8ul=4jjAQZ5,IfL!6*bm_LEO(*V_,4b1:nM&hVR;ge&R0(R0W.bT(fh+P)msY8__m`1B*]es3E5IC-*q8A%K8S*%,E+ajq?/ffdM_=!gpPl+D_^M6!dr&3QlB"qdljH&q^J#>7H3f:c%IO"WG_`G!g3N?9>h<G[;PAepPjcuZ8A*'>mX@Q.uc%5-.[6ha0dZ5SREF42W7=.M"meZq`mC,9jY<1*YCZ;Dp!0(;4nC?ZOD7h6)ASjSjY\g77F"<3jJj]FEg3CKmN,tN@bT@;.$i%&6n4/%Y.JO/--F;\R)-kubENNGPlG9QuN1A3%$tL%h?*$gBJ]9iG7Ia]f@J`q">u>TaF`41&EmF(^2<T.6Ab($cWR)8I36$/A]GtXr`\LG+5)hDJ9D-\aWo_CW[Jp6KT1I@:!W5"R?fJh\IgZe+0+E;#eo*`%Y+X442UmD'E:&jIG)m^ffn'EOOE%X[ResupqdX?+LAW7PGt[>%B-YX9c4:n-4fanaL5m/BWSOH#>?S/YZSeXXe5s&9PYjkg)[-pQ5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qqj!5Qt3<c8=:NknBY;L9/pB9E%6/>SI"3i#EemRbSF<J)Hq=G^%.XK:fTkT)Sf+HfP&(!&(FOJigSi+eC!G)&/jb,)0/t_$"j&Nn*]=r"I^)pdVo*7k/GOaj3niird`D\$&^drr@G=bOS+:5DG5Wr%2<KZd8#tHp=ME[d_V",9&4#b,WN"`W-l(A?*_cm'V19N5'&n5J]Q#a+Eu$1+Rc7q`V.N24:X%Z(R*2*`nYJ:=,cujKJ_KB?1#PB^kbG[L^8(D;R*=*J6<RFo]1?Qt)X,\aA;Fao.kp#QFc32tk&74>jdJXlZCh\n!&u$Ag$pVa=BY$1:6.I`e6/:n<'>]7-;EH)2IYpH=#b5OCIXnV>00VWg8P^:*OQ8HS4%"kdq/NT!^.'C!%*CYu.XNMG0OHV1]pFR*W,ltoQf$kTSl73)@0Y1M"NSN4jbUWU8fFi?2NkB;-Km31I2pdKW3q"I^I;%ogfE?'#^m^.d[;@,Oi1&ZE"iKmSW+;9^=A_]R2_'FT%n^f#J*IIe;IbD1#hL<Z*&<\][rLU4EBi)+11!(Z%!@+21^D+d>!SY\A,7D<53Pif%!p?c1a>pHN3*n-#od/4ZoKI1NJ%U[0rBN<+1Qn[H"*FTSSpbnV*90$OrTErETaqNY-h);>JOm#mm4FPG"CWHR(u]m+"b$j$)%&q17Ml?g\t!0"q$MFjoZ8uh")(aJguqpY`,V0>QJ*ZR$]UgX^rL8>335*9^03%`hrnd=X_.Mr;auWmYKr9($7N))rMfc=lTY_?!dLof4s-(9egq!8[sNpaW28okN;UBg=#frVBiC:3Of'5\deh+UPTo2b*j\:a7BcV'O5k".J$eiu%L.EgdfVhto_R18Ia-cZ=2g5WIiLQoiJhaT!)/_Oe?4a3#mQh27UIV!Jhfe58,iRiReeMH4cH3D<0N<)^AYc9SK,Y.jJ&iWqA&&Z)!Tof4:eRhRoFgIIZnOngjfs4[Z#lGfd@+iaKNQ'9)HQA[.hU,-,CB]+RqpsZ)DV8E2t"Z\B,pO:;\>,ESeGu^Yl"221H*`!4:,?k42kbe>%UpkT1#[Uh/JEGDM==?PreC_*=X&QhITOR@GsR>Gm0T3ll/F,lG>1]@41u3Nlp;V=eX6Chd;LS\5[9!'U8j/:>.5GYmZ(BBl,*YClfqp`89c*t7pje3scq*p2_VB"OFkSnVCN1DBNaJ1ps<gsJQ<*9Sf7F.9dS^DNoP<Nt-g,t:C)FC8(K%"^QupeUUurr@Y!fQ`"jrrC&G$g^<BZP[uUr&JSGb.Hk/[U,*<a!`ob!5TLj];VmF*]CG2U8^T9np[H9W'\.BArl,T8=Bi1L.#TdfV:oV%RV>)k2^"W-Q1%Bc$FU#h=76:i&AX2)oV5<rr?F>I@F2h!lB:cDr)HF3>p\enski+?WMZm8:P4W[$u^<=2U>U4%lOU>4o6.5Y2n<DS68:.]rGoD5SYi,N(bQaC1TO4<?NW*=2`+U%L;>ef)4AdgOE=G$6d!YNs^5qR#F=X)%"/5@]1[07qT!J+s[7cBAgMf(>4+e^E86Biet'6jW/C4*<$\puHW&,6o>>_f:XEIQh,:#:ImMm-!^ij#Obhq_7e#k2EdS=[OO)r*od7)E%Np`t_D1?_0KkJ&$^+?fNa2eVjP?%=!ZPe8-g^UeZ!o6p3H:%L;L/GH[LWE=WR`VI*3u/_fC%q>KKSO//em31-i8F4EM5R3*CZLHKFQHoTWR5@N.M]@2_+)fCdYkPti,j1u`PjPuG2VR?@"kZZg:Ksg4UB2+KBC)V63gqb`o_R_FC3$Y#<FnHX1nbQho5lTHF(E]q@Q*9D3OEc]'QI9KhDAt6D<#*#0_L>fj&WU-fY'f[fSQoDL;.%7bIS[`7q(k\K/hs+Lc29X#O,q%lhi3sE+9"7VNA7%)!(#'[rl`_5KBGhAIAPF'?);S[!!?_EkA>[:I`d-D@e^Q)B1:/mND?g#52E6_!6a1h!Gn8-6@c!@k6`a2qu-oVn/)'>LW-amAuuB36h%.Xq3>tJ]ZYRK9.qGBA0>93,L(\B=!i9#'OsolU[Z*8ldPe2B(u^RS!GCJZd1g"Hqf[\#Jo:3pp$AjHRh#O,!H4sL\YBr4aq!@8"_a81&EHu'gK'l``&YtP0N\&Ble]PGmcOk/;,8/T=e]V3'VX:m9`Zh!5VV5/1;PUpj$R7&eF]LqX7;_a[d/$GfT7ljqtp5?2jp&'-#mjn;kFL8&c?a1j@e&\GaO39!G^VZEFCQB&;2\&6.6U2Y,(lGb(a27J_J7cEd;l/i<DpJ*ZMe1430^gV4!gUKGod3(-iZA_`U'0sCYYUYpmo_'EXrHZuZe^Yk_+'jKY+m/pdp>t@mfnK^IqS?X5*gp@<?jQ(.[^R.bfY*8hl@ITf^/)rLjM_-,%VtcPg1pW&D\r:Kf"5>&1PK$8m=3/r2K\Bb+CO9W3f%5)N$*E>j)kh@jb.urq$jK8gkW,iLK8+)kfBocPrrBiINphY)rYPN]kl-6NjhHV_e[ND6gH3;:.e*V!D$.^[$g?"'1'"PpEj>o'bYJ4h^\?CQ2=3U1rZg0F?2.@WIhpf+cD,!415=RnPRXpqER[%R52c9<^Q6)MG]2T&L9<?D'PUBZ)I0'RL2>rk%N/@[aM8J\!Y,P'9n#l-?WO3U<a'8Thtfjpaa6Q-62@4g5PU)/r&!ndU#K?up,cP<c6F[u?jt;=XE"7?H(1H/XaHW83GK)*rl6)q[1^2X?8euIl\r1rO?Ys.?E`=kfQ6#,LUGkW8m!rfD(HMeStE(@[+;\P%RF4d1XHOb+QJQ!dJQ/s=2J8Zn92A$D)Y7R%3&GqhXV>",8W-FZ=/U4jCbA_lA]U;$>pDl[c6akBY%C6c,QR?V(3j)pmHW<(ru"9nF(rni^IS5rja]Xm9Y//d`cGJ[=?5DEcqbrr@0$;?tD\jj#QcScFr8TIM^JG&)iL,6.2M^BmOX->?f,6=JT[c!Fs79eC>!MiQd)7rr=#(^+?UuBXQ**3+BV3Bj$+`-,KYXiG^U%)6SI-'e7Q*et;^MJ!)IIg'bCc1jDOW6/mf>$c9Ki_VIa8TAn0*C0,1j@k3Pe`q$Hm,Q@7cfZ<bL`d.RapaF2%*@FJS@0_CY\VfFc)P,Y>RmeKh(_E"ij#LDh'FkV%DbB_QM]]8IJA*c'O_XaDT08dZ&62G78t=YkiHbPp6XXj@!^PZU=;iRR=n&I`cuhK09d8n(P>YsNHBnHqO*;r!#[];Wg+kYq#(,M8*VAk]7>Y-WhY4XA](L9]h/.'T(J_0?p.Ep(F5I^kEW4JF!#@FD$GiZX&hc4&`!k\"k^!_/?D=u+$@);?pg<&gg1/(4VOp&_VHIZ"_W&iD<bWe$#f@-k<#<BmkRSNi^6dCL(\i2ZnSa1F96k'oX*B&'9fc:BeRB$#>::!4j/,,]<j;?biCuN5`OAL;/C!1OcEA8+[#s-k]5b6=!5ZYY@iSc#9gVFdFYEZbS+?JLFQIs_hZ!S0O-2[fp]JE`">h20r+PjiHZ>]al5,c=dHn#3fek2?bA7cRE">9f/(4h2c$BhSMQQe*qcJ5YnH2ukIib$9m6:M?@6qTLUD'jQR8mRhGHR:L?a6NGNsBpPcVoSI:qr>lS*^tpI\h;<>$B'D6R62_6/$csfIEetc$I?i_Z'TFfm)sjnWYpn[G>`K.i[`KOe!hR0n`hfjT?QVSF`35X,NgsaP3#??)p%n/M6fEp%'@aVgIX@4WfgW+3&d2GS]W'gA]G`%'M:2$*TI3l4#r;b=dV9'cn]\*NJ._<Ba?hZE9YKf_tm%DL>%6>m"'?KL:$7@gqrUhD`"M4CDP08c3AED>sTE?\K9p-')&35>Z,TmXEfW)rEGcrb!4<O!J_l[P>cV`I.f]@RX9nWW6$f!+NJnR$r/3`Xm#gDcaMFerO%fdZla,jRg3*b^C1&?:iW\;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I!;+1I">>kJ$OEK.Xropot#GJ1U*:U)K'#`H2,*aErjC4S5&!K69T#3`3nV^g[rAGh6U&0UrmJ[1$M=JX*:C;J.e"j\I#.J<EWe,]F>Vu#\9I++!a0u0A(#]]'!!N2gA;uoF%_?r21CpX<kFHJbBD*&7F.qD9`UiB+nPc&,o&Wb&au*6"!6;.q`6/Bl[&ZfoZfmb@hro,I<.n4K3.HI):8dXFj4:4"CK.O$cU"ig(7-#9.d(N*'PAQU?0/?2p8u(@I,DEBL[_joP]CiopCht)Vq/SPde'"l%o0U<e#d&`ZaWdO:dGpt73-n!33F%s!8s`>W-i*\pl-Tmf[VQ*rlg\'B9H>+/l"lWo97#_XO]-_WAuhLo!lY^lp#+1>3gOA[+Fuo*t.;AqTc!![aXT9CQ"%XZg<YP/DF,:E&5jQYeD3,;XhH?4[/$*_YTnuQ*$hW1<S2=`NcWW5Bs2((c`R:[u:/A#E4$^X(YQiaTNNAXHp%@38T59JlatnB/Rd.(&0#MHk4Wno^+")pAQ#SO0gXTfLiU!\/SCsFB>"J8(gJU^4)WSD=;Nu`ok<:$U9XM)>L\YnVk_ll$#%JEdmo(b,>78,/4:l[qfc6N2$[kp1&#&q<SUs/*i`%i7ITM?]Dh0=2DFr'7>2Z$rE29HpG_OZ'6mA8D0.\`WjIb!IF,_H5p#=E5j%jV+`u:WqgOWRB8Qj2&AXCP(D,RWcnm?fK*L`^7uPcSFT*tk5NW>.$)A4!IP'O7RK<77C\QldOGB]B*4n5m9bTa$"?No@dV&:b+*K6%$!N>i,l0OhtSMt!6%M%rr@d7a+3S"bJ*KEb?WdlOe8r)`Vhf.ONF+[bE+7*i`Zhh&QE+KrXVfM`u\A^QE,Z'O1)!]MYtEhOKS`a]LIB]rr='uB.7K51]IG.Y^7JQIYPQ0]E@m#a8@\oO7Rl)<eQWUrr=^6=+18MmZ7.<q4e?gn7Utb!$h$!8.)7E=]`,sF1Cu),PC^lf=([u$3'uC8au7L*#nT!N^)%8K7F4Q@.H,'o@CQW[g'l$6QCVI_841Q`8K_V!5NC'rr?O$&,T1N4]8:Zl4-FPg]6nU-]B&<*8kr3*.Gebrr@2BrY^/T`R+T84]gcoBE%r8@hXh(iO]2M;0.0JI,RA-6*q\!`WL>\ERqi@pb1\'IMD]^n?7``,Prh`-C$n!`WLp^-ifiK@tK'jK3tIin5CD4al5P<j`PemB9ts7@_%T"4@8>\[fcT;Mt0'>q)V=Rrr=Jj3&nqrl^ia4:d%"4pj!7$I(<.@hXZ.\piF2(]f](Onn7S0V!=87hNqlRfhRkl=)k&*9,dqmN1d-QFT`Vp?Nbkp3Bq7?I90%!iE(l>KR/W@(=8tJ5Wng2G?Y*.>qfDN:/df)14Ju$cEZ"ni2b"ZqJGB,T1MAVCXZ4<;+258F;Wjen?%J+4=dIWHWGquVs8HR>0aXuaP`#<7N'91L^/h8*V$muY.P)$9lIr$UM\SKIjLn@B,dUh;F''a.XC^N7Vhbd^CS(ogZrYDg.1-jf'XS4mAkfP1'U@6)e^,8,8p1>3NosOHBRueBlpY1M;[O$>d9W"T:pc(9Vlb+30HXG3j$L,NXnF+EQI'>J,<i*%R1rI$>NU"<rR<![(P;\AH=F3.Zj0Q3q#DX#BnjnPlCa9S&$n*#PM`u9pNk;]">C3N1d<j);NB-n.,lK3V;cHl!HZ4`4C5QnJ%Rp9s;5%B[Ter`gloJcV$d:@L*RU-_0+ggcrF"OE#j#5/s\Wa*F^YB;\r[`RL'mjkJI^ge56f,-H6T80(:CoraeE2p(T"`jcst9j[('!QI7Ai,S"Q4Yum*?aA<brM%"ILYEpie[]PL,9Z/4q@hHt5CaLFjQc<_FfhsaiH+&>$dY$^a6RC)^$o>MJNj?\57JIYqb<:AHCUu?mk1C9^E@P5KHA2be?1E5Z[uDNM5,gZ'PES3%b3hWQ6_t##'3_pc9JeA`MWE7q`X7"g<*>pf9g8QTf?G?&"M:n,]!n"*=Juu0a1JtM+P>%Dt?0H:,FD,Uf$rinN4Z-VsQSC8RKfAM4/o*lK_qh$Bib$>@^rgaSB<`+FeNjYM%5*GZ)St^(Jc*4f:anZ-t:7[=q+^70EBfiYTDFM[f/;i]a!opiL:GG4*@1'%RH4=X&l-q+L,XOo]G*+$O^\l>ut*"^^_[DZT'ONR[!s7rJ"oH,a-I`HsX*B`!lsdarEQn1[t51qBMaqpKn\of):"n;r#rrLYs8@"?M&BKu#D[0Sd(:\C]WNXU8qeHLC_)&jNQPE8Ss@Eo2XEd7&omVD4uO8(3&MXPC.K&aXm"Ro$;,XZQ+7oD$2\2jM'id:L]^=;SJK&>qabpsKZ=?@^i`#rLnEM'm0mG>JG4>n\p7T=@>de?qCl>u!cdB,8e:L:Z*U&P,^92CHMI5Ah!%^0ODorOe>H@0W/@qOIL;7'^8fZ-/9YJ9DmhtC^XV'j*oNID]60pG+8*Pf+u3SK5E;76.+EWBt5^UqO$rPXFi\3uWF1,=SS*Ppq:/*(r5$g]TseSRHuI=KT*HPp[=Bh+HW+6aD872>C6X;"N6?7GD-^P6QPp0T`;>c^IUgde@9)?#!L3gCp^%Wcead[`BuP(XS)*Ns7.@m=R^Qd0T*5MQM.c?^)ABBd")h7Nf6c3F>shVS)+re&O6orEr1o,_M+h8sNOLF7T_>SD^.4-RLr%D?D!,uGk!!;'jk_>55.N/IG`k!%@Dh%+,#?Ko>QF4'CCemJe61'`2;rBDs]l(37BIQ=h*G+,M\/)JKn6P/=N;ia4Lrib?t*sQDf>-=V\MV]X2ZlD2hKCZ4H0dI:,:J1GD>POh9j.1XI>5cuSh[mhY&ekIc(aP/IT)3fYEF3.@;0^(*f=I"MZ?2Y/kIbKB.=6nFVF"mVQ>H%mpF#Xn]cTZ4.bq&)0d-(HF9f#lR/Hm_YEuVEI)8-bXoJUu`uKRbcbI2B1W'"DfCr-.!jc.DD$l/G4n:>VK?cP"R'0,r)T]oR4lmYS\PnVcWg[duZaNhGh^;HCInI1V+g=g4'S%U+M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#'!M?#0E^MCU;dbFJSpfVU65U2?.\p!tA*p-.5'&[Ya^Y*Q+4H'iIj8ok%d9BJM4?Z6cVX2\DKPErm>;Q*Jf5t6s!"J5&g1I<u/WQ`?,K"M:4F8?-e.Bbfl%2ZN3W_I"C[`S/(8pX<if95^m4C`@B-nS09^Q&bAmrD9NnFQ7alQSe0RliICQI,O8H#4Khd=bVLIC[f.&npG"MoJA5$6rRJ:YM""G+Al@rLI1`#j`*-MU6n8b>4]ka,I*UCf*>gdVXlUEE*d#tGj<jopOaEF5g*ZOB$77D\ECZ2F"F+!Fu%;[GX![mki+Ho1V^iSTRM%'f=eL@8X%oXi$M$BLW7*Fj&;l`'.[+T<,,fASC"+-)pLp_BqqVr7Mg9*6NiF)#m?D0?^4=,i%A-b>CZOpK>`lX(0P_,tj'4![O=iRXEshPt)Q)Le^[BR'TKNtd7Xj,MofLW<m!Et_;ciP"IIeL1.FIODNn18QDuo1"1lf7<kW@(5Klj3TiSm(hre!'d]6=3;R/rr@YQpo<Rh9b5$c:6RX?"/oQuH]BoV<(4msl2:Nlpr3,&r'^>G-9PGj.IJ_uQ;'!X(=n>&2[J%(*_%&ASk'_]<k&Qj)%,l6<macYmrtPA:\,qGQr.t\@B4/#e^#mR3B6&=cccI^]-*U`$t[,-k%i\c@h7FFe/o2jd/O+90P1Z<!apBckHX1TVd>YM?5`7HZ/[ERhau2%]?P+hS^3X8Va=sWqW*?-^ulu*o(D8uoGdKcrIDOJi'/%B*^0&dnnGT0EuD(O4!n*4].5LHP6F2PNYO<qAVLITA"$lj@Bf?_=]rj'QWJ9RQs)?se;Jq+1k!F)0+-A,lb[tgLUB+[Q5Z<qQBMA*6Fr;hH4c["fRRc,cf58Im8r6/`*I/qHH]SGlm616!Yn;c5B90b=&Y]=H09bUb?mI4f3bhDS,5a$>!%XDO&#5BQP4j\l3Hau3BfjGlk\Y@<@!^VKCBa*B!<"T.f9q:anPf81[)*r?`ZTaplY@3AZ/mKQ]PP,gs'V[D^*L2`Och/j\r]q8C#Wh>S2V(l!L;0ZB+nt,>%EjNOOX+-f!HirZ[EtEGL_SNmd^`mIN'N;K:UUA&uZ0?_(LdpjM-DL#+/ecob1%ghAgOYps1OjP0qFFaX,05fdr-PJF>CV^$09H/u+`%ic3P)')I5Rf*U5J]$VLP+Tk"lXT*+=/gnC\'6`*'*VnK3-@G>+CoW9rfndY+8dbiWW"=D*jeR)%=#JL/LiXX!0CLSbI_=lEY^Y;C`$F=2YZn-e2:V..6khC92Bn=Hef'(ObcH<ZdWn<ShlE^R0Nj98*.^;4\cm6`ce7.[GP!Z=oP>2*7BaHP%gP]^U50N+/Ah\^CRKN,ao$%8U22/8CNjR]?3D@<^K8"6chJ$0p#+Y>^jos!!]hqg-=UtNgFc=DD]g$p4g&&^lk#]1BPhHk<CB`Q7%b(1-?T8O,4sd:W,.a5I^E_?FaH]F\P=qBW\$kYgUTYo$MJ33:p36/+pOJD#KoH0A47Y0ke.4>Kp4/'5Dig-6DGj@JhOdKjMZ\P"@ijh(40f.SuHhC&T4D(Ja>[MO%[N:.ililHhe^O@9:#&fB+BU@8m_^]X5.BVN3@q@i@.j"Mk?f8VT\^U:5\D;.:7o8h+>p?Q!;m'=W<g+VFY)f[pg#G7CTd$;`6PKt8SgD.t\AE2[qND=NS=1cRT,6uFPl,rUX:TmW$+7-K.rm<q@:k9ehfSAP6:0[/Z-^3mQlX.*Mrr@(hiVa:AO7AR?l@._ojX9s?YN!CgYK!M'05EeAV>+@/"!X81?-!,iggGXI:V:?*5>Aj:pt!dMa+6,J!#/eugZ_a:h%_1;,:`VrN;$r<UYUWQ2gc8-IK'<7,Pt#GQF`:%I+lT;qMqU4WB6d_k0(Dri#HSR&XOL-MYJ56UDV:R18i"nrr<T)IV7#>1N"q@*T[5#YJg<"p4*)BJp;MB`'4O?2lq8PgJa<S>)fbu\GJGL^oFT(7+mNN&?%egl'thJO8('B_,.Z=%^XORrMJEJiu$,<lmq?\@S:rD.+`9KTi;N;F;6*HoeUE#k2`PMGI@-+@t^NmV9$C2jb*R5"PEK#agJ3-L);&!e<lHKgU7=hqO754p?MU;]K,I/_`A<b]GCb*l*K384[C_R%,5<$\gP[E+>>hTkk2./C@gnTh[JQ?_si#l4qhV[VnTKUZBcVM\6kgPT&2<%c:8#h:('#!d_nIPC,[*sS*BldB3PU5<8*"'IYZlS-sQe,^eb=W@j(Ea39RL>8"d'=DqK9n\,7hMg$_4mmS>oFdD+[>HlnXe6\(-9!+h@(ERQf?hficdNRZPR&aYr6A<@-Z6Y)ciDE5Pnl^fWn:\Z8$`IIYNIP#:U%(r4TYjiaDHXr<b2c0Y!'RI-5aX80P$N#eZ$h^#/S9K^ge#D9eomN*J(Y;IR5>u6iX3E1LgGI?_80V)XOdc[l"-QHW12HGmdbO]doIB1<h5?"7RuKo26PZsYQHpiR%cj8RNbdgKCW8:S.+TZXSF+2t=GZtW<WO9q\$(7kn!_;l[II-j*,A"O6;pC]@^.*V!1'F'Fr_'4_"?sD\Q]M2L/X_3&-F!L/(Lo?cWpJMIm$'CjS?N:*,TV(62p:8HbTKM^@V#6V]qE:MQL02o)';B?K\%bhgbsU#n):Hl/1t8YJ7>($*6Ll`,94Y/YIYR4HbsR1`6_T,E+5bF5*QO?67Ej%XO?_MPsp(a!64g3p-b6aQC3OrM.(kNDAbG#O$5oZ+#f(9'%#jCT/7^";14(c>Yei(r7TMiTq=)3Q4K!7r@>a0C)$<q&DE>>$67i<i5=R]>*\"2ngkkEM)5tLk8dP@*rhYV6!;M#t`:->HUQDbNK.MSgu0\f0%Cc38Aa(*&,OqN,eTI*IT[QCW:IuA3S8Y#D82M,jr\tT2F,45+/RK:=U3s5s52f\("gXlr[oUni.lj7[=7E(6iK1<`/k2iQoUlLm;,RbBA5uLTW@t3;/*^`,%Y[B0T(1HB7R9fUi@q"##D9FOYFjcDPcWWYHYnSUo,W*rc5*G`V3\n9+E?(QA%Q?u/[-dr"2?H*<BYi\AT7NP;3+^osnVjDuk=k&b%\F1.OdQme\dn-su,.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gX!.%gXPh]2PVnB]%t(%dP$k]U.tT%s-#OU'Ng]T(G\h+0a&d8<m]3'M#f0f5?*4t-2]rr<20n1MI$PB]a=HColOEY":QT@si!(toZ[,Os&<4*@_QeA'q+^+tRh)LmaR4/b(r"k6JgOjJ'@nWAchT&W!"oYud_.Hd)pC>RD<WB\FEL0+jHh>'jk]at)K4lQcN=',0LVHLsiKq=h]c_j3EN-=Z]]f<3'n0e,HrrD#5LLc-h&F*HFM^LlXL09hng&A#hhs::B/NQtcPZ62Ynb#nQ96s`i>(giSGWYKpqOGTW4rJTDiJ*]tS`*?Tl1tR_`q?Wg;5D6VDnP8hM)Ec07<l,&VYR%UcK(-h5t)JeN8m)Lr#P9N`a'8T/&iJB[^0d+jh-,>d$)u",*9pnF?JJo2=^F%5N%e&-2$?N4qR7\cBaD^/Y9(X[j*2M,L&\I"-5cslgIFrdDKQUX<*U<dd=XCSqf1.2(IK'DLQ+brr<2!n^#oSIi8$.m,O2e3Qkq7'^aY-mKl*b?W?fErr<2*n<T&T(!hiO=/^A1b96bH`Z\n,!K<e^kB:/rKVA.D\EL*\RI4K\Er/LU,`Esu_o:MtkBm[,o>=oDF9lta$YZu;*gmcu"f-CuEK/9$H/#7@`09Lm'bj`'.64jd419@/P-PECU82GarrA)Z!8s7d47QsC[I%]>(&2r#2%05_UIdTHb-'fUE>dr2a769-KAZ/mmi-X6pn-N+'&NDM5eFANYL;]<@!TZ$WT5H^j!8-]EVS/LAJOhJ4i]U4c,j/?fkn"W/-Q20CMW3[VsS3fGK$0prYPS7_BIld?Vf(4mclecjhEQ[85nXV!\7pHg>%bJ($@fdVsIc?q`";.`#AB+FY,CNe?:ITd`JlcjBKQ,FME*&"cC;Z*>>nSqSnEaiK(/N1W%-.O*s6"OjNUePsn^@Jr1t[4R!2$U4>Hmr]G\H2LIg\'B6c_r(Z.@Imhb-X]fn[(:SlqQ8r1P-Rt&Tg^+fBK8^;JcM0'l$*3SX^n*7-r'dN._o#sP9Y-8L1bE[?atR\&7Dc;LJ3"<+lh$'lpZ%iT@nfk`9j6:'O$2DL3HJD3;CK?nUIqTLKu4W.i:k9>EF1nWJ,$0"*`!4/'5$&104mO)lj,ZRcU$IDA$N2_j+kT^i6=+CH>L.CDG]GZrrC*N&biWbNd139I5CH$N7'F5b[%b1GpN%,IOW5rkHdr;_`_AFqgWhQfC&'U\\d#AZtgb>=tbSRIK!M9rkL9!7p^k"pf,X9!<cdB`uKQCSO:LHVr2lNTBTT^`G^U!h[KEGp=Bo$WEeO9D4RmOLJl'4;3@KL*+pMfC^(C^O2TMai?QTFDTRB63k*LBT;CR&'JPo"f>P9f.dd69?\7S80RmbSNX*Ar1qk'ZSIW>]$1h_e%,+&(:'Vr0!W_Qn5*b\5QD6=M\ROu0Zb)Arb]$(p3q@U[KBlP14]:HLe7QG/\bf[gb85G/rShcfjQ$`@]f>q)\,hXVQH@5O':b4iJp8;\m!cA@a2;.F6\hlX_adkCB.icT!%"pXX(V!8H(@s\EK7c[>"1ZAT:=[9)]cYbWeWp@5n!b55n#L:lqc(TV0tN(,Q&%aptar9F+"IYpeOSF)qiho46LR6:-S3n>F^8)KsP,HHia".YP`D8MdbRm&HXN%8U5S*T.87hIX)n:jQ,5"f-,/>,PIbg^Ve;8iBMp9h[J^FGoCgYGRW6^,9C#Y4kYie2&YO;3&pdPHuJL[rrC-!$sde"m#HhCc4)h_)d?EBhV&YM*)WY772u:4C7^;5o0_CB.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!.&)5!jSgD!p=nQpLLe,dXLCui[=FcmO4uhe1,<XHY'7oM$FB9[LSrTSE#aJV:)"Iu:Z5a\EK#k.*\g`@H)rf.db8'=f7S/\+qG<Y-2"`Wir*Ll]($!&F+8To:NJU`B0FB/p?dq1WdJIA^^^;Deu^S<pic8Gg=>&HI0kpY,Uph3_t[=U68=*qn4*-c7iWrJb9M^/6'c+G!$0BLrrB5ec*_%Z2'j0?o3Y_jI^eo5V!1L@V\_q->A7rVe)b']`?$D2n:lL:X6R"dG':qE[Z%O*GZ>f_Vl0,.&:?b5et_aK`00E;gOi(bmGM<5+<2k`Ocu=*h`V:jI^e/4adNHq4qHpB)Y#pTC7:Z..c2_1P/:c8b@pLr)>T%,JKX!3ISG2ipg^H(+7\d$iGT:^Quso>E:4ViB8hpQ<B3.&W!An`H2FJRWI-PDYh=.JiiB9VR<SN^m(D60q(H+<N]>@"ju!nmKDi`<nnE;s?+t.9?+1"Wp`KU'^`<^&cV?X=o^>tT)=['jj"D"skdi@Ag4lT*gamX"Yl)ftYrKfMiu$':5Qm6i=^Wra!-_p\!1ls7_#!udRE7U-oh4ubrK>4<]`C6>ii?qQ0@aPaCMttLVq\['&:-t)=Qb3"orm"(/:95L/u5mnA_m@d>G%<lYk#_.Q#5'CZhl6Oc+79Kh=0\m3>*j7&mkg7=4C_!N3_L3.DS,NA;)&p8`Z?6asaI6X&bd;Nibfpca/9L:+A!O"Vag9Q5!1b!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!.!295DCn?5g]b[Vup,.6I7[hp089mT;h%&I>P*ki$ZB5FQ,DQX[;P`*/dI8"rRF]aErMZ5TF0E4_rkeY6q.$KWC,n5#M(+gttU!fD0SQg3LsrQ3LFsbM7Sn>uL6CkM.TNO4u2Y?+0^+Hjm@GYsAn[FG+?bbF&?;4EWRMa,R0HDW+15)(*(QU:us)?D\XBCJo=hq<F4)<\>$<T:2CV=6sdHXE]O"'>GT&;Hi>=9ZAYC9"p5GT&CMu='!YgN"-)9alkb`/#9#ES:3N%@9;14q(BZhH4e'4Os*7.=.FAd'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+!'N%+;s4IAP~>   
endstream
endobj
13 0 obj
<<
/Type/XObject
/Subtype/Image
/Width 609
/Height 151
/ColorSpace/DeviceRGB
/BitsPerComponent 8
/Length 26976
/Filter[/ASCII85Decode/DCTDecode]
>>
stream
s4IA0!"_al8O`[\!<<*#!!*'"s4[N@!!<9(!s/N+!s8W.!s8Z0#R(A7"9f,;#6kGB$4I=N$4@4N%MB<^%M90Y$P4'b&JGin'bq,f(Dmo%(_RMt'`Znf6NI8l"9eo3#mCJ='FbEZ'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GM5q'GUS_!"fJ:QNCRt!?qLF&HMtG!WU(<*rl9A"T\W)!<E3$z!!!!"!WrQ/"pYD?$4HmP!4<@<!W`B*!X&T/"U"r.!!.KK!WrE*&Hrdj0gQ!W;.0\RE>10ZOeE%*6F"?A;UOtZ1LbBV#mqFa(`=5<-7:2j.Ps"@2`NfY6UX@47n?3D;cHat='/U/@q9._B4u!oF*)PJGBeCZK7nr5LPUeEP*;,qQC!u,R\HRQV5C/hWN*81['d?O\@K2f_o0O6a2lBFdaQ^rf%8R-g>V&OjQ5OekiqC&o(2MHp@n@XqZ"J6*ru?D!<E3%!<E3%!<<*"!!!!"!WrQ/"pYD?$4HmP!4<C=!W`?*"9Sc3"U"r.!<RHF!<N?8"9fr'"qj4!#@VTc+u4]T'LIqUZ,$_k1K*]W@WKj'(*k`q-1Mcg)&ahL-n-W'2E*TU3^Z;(7Rp!@8lJ\h<``C+>%;)SAnPdkC3+K>G'A1VH@gd&KnbA=M2II[Pa.Q$R$jD;USO``Vl6SpZEppG[^WcW]#)A'`Q#s>ai`&\eCE.%f\,!<j5f=akNM0qo(2MHp@n@XqZ#7L$j-M1!YGMH!'^J^;kf-t!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?d3hXY-UEF*=kCGl.U8cg\p)9?-B7"Q?;2VT0<I>>lODoMrbPqQj%oHCV!2>Z6ZiErl'ED!!0rBqA=NdY*JRq/n+CcZ-Clce<D(Sj#U73-Z1i"@QY8`#7b&RbN#W1gS'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N%:!'N&*g`t&aVT>KIm]M#8L2bZqU`0Stlp6L[\;TGJB";&eMmL.g/GJUdXc:TUd'9\#RT0kO"p5SPVVoG)f(!3Sr4C9t>\m'U+jb&]mP1ehmX;iQC\(lL]p\*/9VGm28pj@]d@5!Q3W8tG9e>k>m%Kk!G5W^_T3ou(sqlTZ%IH)ngkJW!Y\CRf.fB'M$c`&b>:Gh@tR1IM4?r'OB3;J1IrrAm&%/aDiTD0gim.l.hmh+BPO,c&\*1%^FWKK9+"ci!o\=Y@(_llk'K93mXf%.tgQb$:V^@aW.rjs4O4Cc;i;hg@,o'bp\qd/.W)YfjS?6duQoe-UGNpO3T-.Z5$B9A3,e8I>0DX[\^*0Kh'hL<,j?X%8gOPSUF7<`N./?qtQLIi)..a#Y\#U"^[K3s3P&c<$>Hnt5`Zf/)#TsrTpk%/(oZEk_0<RC0s+R]Q1AG%;\p;d(EYP,SD9C#B,r\2+3[-,X%p7lUM3KTAm7s8_:-^6a]/[maoAF7[JfN*dZ0Y:InH$B8&1QsK2b!3G:me`WOe5?>b!Y.NW&PHI6I2GgTMH$$%Ou<gi!6XSI(`n>P8rE'5hSqI!j[d7fHnjdd!0B;8+.2_sg.L^G2XH;b-Li[KKf#4$n"j.HNH,`A$_2cu47Ym8orjI\4tGq8h[k:r/mFL&`nOn./5/MBaqc`8S:Vh./q.UKOPdb#prDo?rY>^D[ard67'hu2@ol]8VYLGYg;f8DN!#0WF2)OYh[R41IIS,lO_O@@\(Dl2/`ji-m%Yc`5k>7%1-4K/5C<.>P%ONtI+&rA-3dLBm^g.3L[/)$;hiKb1WEqbXHVP9rr=s*BAhYcg%`%o[[PDr`g2d]hH[5o2M6XlhuZI<S:d>AFcQcPf1PSiRl12-5M@]`SZUT954X5"6?pBL%rafP";BaD)a5DtPGR".6c6#;Y_j]!fbM#>i%/Ve(?FD;aZ1?LE;UNgY7g.>7u]@SUe!/-jjk;$hG<qA64bk3F+ll'.s%55o4Kh*^ZuulZ#m3J>h7>!cV;/Qk3;C%X5L#<PNCBc?eo#b+(rtpMGH,UHt.+#"G;cYO34)%IXFCX72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`!72,`$;F4oV:@'?/$]r;Y$N.^3l]L'gR0HhC"7mW6$4Zk^:#R%Z^*i\Q,^g0uMsH\[@-iJXi*?ND`,&s-YRUsEP":(d4q`69nL)3"LjDRL1b8<];6X]gOtk^4)*)Bfk/Pm"od$+mn_a5UWp(;Qh2Ts=r%VLAf5Wo32Ua*dPun#co8TPV&WUr*cfJNSce3V_Jj)#KhT('E!/39^dqRE&[jV@@GZfspKfK;7i,CGC')hf.RjupZ',Hf!k.;Z\HlIcXDb0^\j.F5K"8:sR'rLd'_/_e'CL_%t$YT9A='`OWPeT-o@S352bbklNb28RF10iRK#20")D5d9.0X3,gOWAu]2j1JI&2Dca^2j5RErO9I&G7,uIOTrh/'XhrZtZIAq8=^.\=4GZ$jan%gW2I7NV^E!fBh<8M0*q9^YkT']P6Ct[EAq(ce;n"^c.CU4*$h)EQL3gS<5/n/47VHrC46&gX6"lT@Ng[j!ZsN<FNZ8GQ)6^I_q_b_L-@mb4o&VQdO":N?SD;Fs.?j!g'-n]8t:Z$irK^d"6_PYJ<p<ptJs@2i@72&bp9GP1*R?SSkR4[gfOd88k#Q%(OA=#Bt[nC&9jd1]Gd*-g_lBp<-dk,`W=+'G,#j;?$W#CN'@9IH0niOk1b@Jjp,m);\E`<IL]$mQ\MS^uAX%nkX@S"ap"?6$uO&MmMA:1@5rVd;PHuP0?Z>&pGrdL-fmO=:V*AF[$iE.jp%Xa>BGKi[H`j5qiA&nf]+[-[-FU"!E5fjJo]4.t;\iYVA(7cK)'RoB3Alr_rE[$#ZLuh>CCsDrLUiS>As<E;RgJrr>LQI_!?V)QM@Q'YW%s?1$2<)I=<1FWVCap@^C"H1r!AKLtat0qH>q_VgGL7jG0dHh<<FYkV)RQun<.rm@fPU<(WlR@URmF8Nk8#jB<p+*b!urr@`O"cqX!Jc2Ek(?\o7M-60hbZEm3WL#RHILfAC36lu#cObBUc/75%\doM!*L,`&/jKaJo<iNJbM8VXJp24m0Fo\N\rpF6TDhH*A+LQ"fZm%f!!XO'?_QN6Kp5M,Sm8/XiJ;MaI(YHN-_E*S\dT#8gi9qj5J?t)pg/=eV132drqBI+:sSD`Yqbf!r9Q*>2o!R^4L7EEgV?Z^E13YuI)7T,gV3u:(G&&9a38n#L@;[A:K`W171M[="!e9VI[o$#P%=*9^:@HNFRhP!k;maZoh$,mYF+T'U;#^`OJ7U\!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!2>?!!3ThPrW(Dr,5>pM6e,Y+CFcZRk,UR4+M_,)4,1TP4Zf6^L?[p%N1=2)i-[7nn>>Nh3pbEVdO`f[Luef*B1Bnl#L#=JJdL9-qRM+4r>"gF.BR]m]b:!K^9Eji(@rqooAI\"A8dZqOiTQN>;CL@LjU^gi[9GX_DGZ'o`oIA[W4EV`+0p.H=SpfVOj+)W=D^#bZ3;,L']uI3$`$nSE/in3V4i^AR6.Dk%^>[kN%-[ZhlN(n3=oEXlp&Ti141Z7;a@Ulnbjsp>cErQP+\ZIe+%jo@O!BJp_gH;pmmEm0^_J:j[UP=%Qf5[RWD3@RQLAhE8]1<`I(c'A%Hs5.ggpJt]L]g![\_E+Jt"LHBr]a3/Em)u(DEa0%5D)rf2r2X!a0=a28h2-?3W)jpQoId05/r8[tOi8F4:Fj;90>Wle213pIBaX=9d5&._F*+W#*>G"o2R`sL3M6F*8DO+G'\g[!E#!a%1dQGehDYM7kinaLhDuH9A)Mq?&'l$G5q22:a"#2#$<&C@&h+rFj)$^RDSe\8$*T!i>)p2>5/m/N;TAF.S$jcH#*0,&`DBF4Lms`=P;)Gb3%m2p89!0GG=*'=d@tTk1&aS68,G/?)4r_AV)44C(=5N%_8bYHDGaB"D$^T5=91:?Yl!kCe5K2Lgr$Tqban>U%@rnWjD<s*M2VkNSFXQuX/24(!YRX5e%E]"?C\+/*^*n55j(7'5H;sXig6RpR7fNHSeh#\'qCm4O_!dAQAimQY1"SFL/)tQ#]NqH5>4?aS^Bs,oGd@>L6a42Nn%:j5/\IE(c/lF*DXRC$X"Mg>-On+$4J)pB2<-n=Hu$LlVrIX\GW$l;np#@Qd=0Lj\=Ppl$07[uN)UO'$A0qJ^HCWX!,&?bTdiZ48`*VL!"HL6jZHOF8]!,Vpg`/spAL-eOt<P.&L%iT%!;e&KCq)Z'N??@Z8?IqYbI"(La]!T!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!%=S!!;QQorX+1Q?eP"m0db`1`$DMT]=pf8!,J1@h*"$l[D"9lK[>e6YJEnD%XcI+]hV`ujZb;Dc8[E5S<(@qpRcF)!5V4"qa\I#3^)Rpp:NelEi"N2*LM>'+*@1rIBW3klr=PAg/#SKR6FOq^f0AKc23gQnc&Tr4`e67h3i`\/ud$Xec,WYQemc2'i!!eRd>B,mFt46>^rS3+hK]brr=hqdI;X1ISl[H:@+!FGOL!upg#+MHo^]GL/j?SasK;Rb";D"+GRl@3T[_rSuqPMmH_lobSoHEDV0H?aa`.p?f#`U7Li163GmH9lp$35,(GB>)9fA,nlWp/A&'[H\Kg5s"$H-qSu4S5c!2H_EL#q)^Jjl%0NQ!9p&,De5!O9&iR`X.BAi_1;#"J#GgF5FZYDOTmJ_ldW*IY_G:UPS`FGEcN[.ki:==-PQ'8iYQu%3c>'RYUT>3W"nQ(:C8RN=rlW@BTiL1E*9nE"ph/XCN!KGiX@j/R5rrBD:M"Q62Hrp)inB05!f7!tOHq.mpIs8'[;lhoZXUgX3db7_]NJNdD.N";.RDZl1B3Ni5(]-PbT+%(+p\t4)4?WHKHLuD"Xh_K\d\cWKY9HQUI)sGFJ0R5P#;>t%V!:dc>BbDZX6b9qBZ>??9$p'BjW/n@'Mng!'Mng!'Mng!730T-q0ODXo+T>BX:F@POm4qHqhcW/L0lTEW;^7OM7%oi]Q-/*,G/s@'%',^!)Z0!!)Z0!!)Z0!!)Z0C3>-#V8D.<.!L8o1&:+n$!Rst8!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!#/:!!%)C#4o3V2`(^S2,sr@5g>Re;c8OVTc:1")Okdi-Qa0S?0g*D._!YMh*i"kD\>?,:".ECAV?'+":]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:]X!!:^>4:\,EMb4qDAtIGt.*$T*5ObCU[b_i-=l_;cc6./s9$I`StYIaJ',R;NbDD@<b^@IjL;+2#B/oJt4ci[dIqDu4<9p:l=4QMJXcq0&Wao5-J&gbNr2`:JQ%g>>&Bb]Y90G0mC'SB8!,Z;6f"(.Z[t9]lg?[.CeJiQ%G\(cKrN<B&h+3@>p*->;1>.FfeJmKj>L+Y"Fs5%51thK7iMc>kpnfpD&4Kf;KeiV/("9-.EU+(F.D^gEI;Nu[c5cJcn1IQb60Rom3CC#4U/Qk;"uM0Se[]KCSZVFf*7c=QkdiFK79i%GW0F?$TlE1e!i0?c,j"0Q^.8^:+4rdNfF`u/2al2%a[%P;DVpjZYtq6/gKM`c@V8&a1`KJe84i_L,1@K+`!P.nJ?AY#UMYg3cq8.sQa5^'[HqoAbk+oN5NB$kPp.<hh,J+0<]ph+)YVXeS%D0"*&Hg/F#&WC`mLB6%^DE)Q2?]k;b@>i)H+$LA5?WQ]'V;U5AC)37sZJXpCZWSWM3XA&Uj>[Kcjak5q+9Tp@LYu3uBAe9n^Vi;Scob[8Ggf1_!/+N;S&mMs<UX!_\be^E!HRN7\8CN,A1hoXr;Qc,:,/=\/[W4!meY`:Aet*LI1NFCU5JLP6n"de!%=S!!%S`%ShSW@)<#AW&F'lAV:nDEb:GVkOH;C27XF5"PLpP!G3XgmUVYq!0)&#O$RVKoD(W06=QRr^Bu0GX@F4ZgS<llf1OMjU>rTWd0]2./q0%qE*P<O04&5?%/7gMamU$2D\E%XsHm.M.igZK^88N0OYdM5]97+:3Q#@!5=WS\frp2i1%=f:p+<S8Q(%Cs#](h!=*s;9k<Lu:q^BHLMRe1W*'(%ioI?rK(h9P,32s1"nGm=kB@sb6N^K8ms-)pZsrl7L[4D!LT^QohJ8Z,*!(p$`fc]]#[J!!:CNu:%*RF\?,eo+In<3jmI^e0<GGHU'3P\6-`1.Seuo+fAp6hmqFc\=JLQ2\+4,_o3a/[YC*#[6BUqH!Km"@rnk:4!CNP5I3,eZZmZg-Yf>6IGK'lg5`h$HIK7NH9RC&_Sts.[H#b+X(%nL.`RlSpl+dB'.7fp8cQt=pj^_L89kqGlUh8rmJPro#j3ZcRkm:#'LUa;BIb"I7i\Ll?ip.a2<B<24M8pe*YjjLohD'QU03)NLfg,_uVX3j;*\qQ<a._o'Yrj]S:A618NU>*a=9:!RG)>ANrLE7<"hPf/1_rp.;'<:V6/!Y)R^JVclb1m8KaZ]Bfl,Ug&Eo-TNOl5K2S"T8)`\2t.>MppFPi]i'>$a_PUh%;K0<7nlHU?#aUeBc8]<1@,UGi.6m@D=u!gmAJqk-O7f?XPo^^h6hgdG.%Z=i#c8b,+BV>1;L5tK?7R;?+:?-JV&3"H@"X^3>M+n[G[N]&9rEZ(QA@o[^Dg4ko-,cerM,cYqi/,[t.gk(kfV*+1s\@UbHV%+T2+C)Xr&t+&hr9XB=f"`PqiWM9L/>j'?DD1FAo$bff,[AK_ps6!^-k&i9,5ER9U;<1E]5?ddG=IF7\OF!SB+0Q!]r'SD$gIut!+XBcX^\mL7U6*9A%;gGj`5M?%c!E(X/IUm8j'>[rHa%oABnrJ<K%qhm@bkD&:&mNDFV:UVW/18/e>>8:<YY,\5bA=0?D"@1bfa)HLO!c;tSS,l%Q03t96*)mVBm7$imt>R2jKt,m+A$<,`6GgP$qT)DaCX>>I+h'ubiFueY.r<ZgeOk?qX.#/@^LKjOF<NA178s@"YlRc*C_P8_u;=<4B%neRb!mI[lS]-&l3?k5Vf+"!JXBGR!j!0S;d7s`*5lA)#ROg]JXt[EA!kBJLC=hS[Hp71=n%b6+)7QJ9g=1K>S/T6`7c!*t*H;n9)B)^9sX!RPis,G@:ul-(N\bb0^EMV.V>g5qeU76^Bl,j@M%uSWeB(F$@lBW+6L*Po*'(d"VdGn]:ACO3CHQbV6?(P,)pOF>Enm+E@1^O/X2.nXd>K.FC<uHp[>Kg3"JIC$+kSL;qbdo67-IdS5&kF2kL2L.L<8@C97-41[?3o/g:qG^_<"*\u6P0+3#ZIg`-ei>kO&^=BV?A[f.^M;hY+5BuP;fp`+p7gm=3*Qnl@\J*To"iRE(m!U\PY4Y,tA7[;'Oh1]5j4bgM'\R,$fhd(e2^0qFi\CON&i^aHrr=#GpnleD^X0>2i#O-t&EnG"m]gD9Wp-^hQ6'#0A3H4<a@[`EJ8WJ:7KCX2o?i"%Bpu5Yr\7Sj[X(?5'@=,r3TdmAp",#Jp/dD9?+1A5>e2%i@3Gc//Y;tB]Hr;PO#(;>M*!NJr*SL]*sZJBlB>E/l>WLJXhKj2f9=IkDAa'LP.s!BNh[Ur4GK!q8bbYSnG`KG23"'4Ksufn340TG%5pa(=*7P46uH:dA\_Q7]eQ)$T$tV!/?mL6+/iuHhSF8E@:n->a_^lG&Hm`#%!Z3>%Wf.&cTaYKHp7P]p_BW.pm8pUiK"Urmot]NQK\uf@s'W//5W7j["XK>0QO&k@>Q/iP,.+9VYBuiI+n/k!+4@NF59#$HqU^=P@o#Z@A[gDC0Rtm?#*0#akX0+q,T`e!"kF_3e@\'9Ylit1$:&s)[PL;5%&HY"/"\DnXkTJLPU=0nX!;G0!!tnh\k\A7>G'S^:HkqT%0:f`:1<uC9lbBW?ZTB_k'Nt#)V>&B3asIonDR`D_u;dflt>`EH)ln;[G,ZW]=W-;GK_B*JiO286P3BBc!W!bkQhaL[`WEr+b(1\qa<8"K?6`WPbUSp,96;:l-a`KKh0U1%V:fEpf:65I<A&4;$R#dP#.F\S)``^:^_XC$i;#R"5oU8A$'^^lH&>l8-?U8@5eUlucZg?3dipj&PUXO)a/`d`j$UA2=h\b9:?1bod-7=[.7[A.1\jptJ9i]Odo:DSOPG::`ZFX^b'i<mhlu,AJPUB`.Q;/;)#!`U`)8RE.MOL[Cp)2(a5.^\)FrAEN73oLFp+BFbCH5Lt=jFW%A8AW?o*]U)F$H^LmOfmm5'ABr.SpGg281?H5(q#00T#jY=O.;c/2MY4)Pr`&CTSL+'?[No<r%!`2U&jYQ7)$&c>iVN8/iZF'sVo2:s_>Ypkn=H+jiN#%epo\$A/Z8l]o64c9q'mVNa1i)X[t*:=[JcRPX'ZH`P?uaTX]iTqpIET5TX0q],dG8\2:si*)4<a%_fNGRe<;)A$?0(1l2G&@Sm)TV8aMK'?N$RF+er1bG4*cN0+u1^$X^@,TC@j)o'.fHDt8AM6n65qc8km""5E#\+G7Tn<K6oQgfc#b.m-X78**IPKfl'i&6K%+rkoK@J&2-b"%2T:0+Z=&q"IVS`TERsW(V&GUg$:M95S[Ic;JNMDc2s!6B((MS>dJ+e)2=,2,>6?2RL-JFUN%Up=fB7:R:_%2C786mb/qW$HU#`WWqCCGN0rhg!ui7_XQHdbTSpGOh[po=n("#j3J823pQJe\Z\@P`h*MZXKfbG/Wb2^,Rj>qIC#h1NO5'8>GcXaghtX7.k.k6AO2T+@VF;]GLfd7rrB)a.!V6#)Y],s*uk"89(8FUWu*]U8('817Y'74CSjX)nC$dC4I:DHN"FbKcd1rsC[h+cj7e)s9fhLn=Prm<:q0XP-Y0/nCe/@H3#q\jq88DhU6GS[rI*bHX*9&;U"T?0pqbqXL<X96W,F;r4[GKXr?k7GCV.d:WYsM=UWXBKGp`\R"!s0hDhh[<r&O:*CR?sCVpi$m+9gngX$QGpkR/+;ZUW31X@WGC.`WAi]XNYD[u9sJnVfMeDUg)^2#dRB[<VhpD,mo'`L"m#PcI=ZF1F%j^YBnBGYT=pgbbAO@IYq8PU3o,1;@K<+dL4j0jto2a:(g&A7p,2Pa#(O>3W#tDV#[tpp&ekCZ6\=i/9\G5DZ]43:H8eeUC@'mFpO1+1sX\O7+]D1uB28>/,nO4UTcu9;q+%_/VSP5os:IMD.'OI&B/uHAqc_T_RDKdH0l,`*GmMRbjZHF0A5bWU#l]'&-!ThD3+`g*\PZ0OQ@lI-9YJqp1r5+!>K_^-DFO';k#d0U!u*,rc:Fiu>>RpkMQ*9;tKK>g='E_rF7I2"(fBiO]K$'K:b9];rb]QOtC,=cQ>SE=h"SliEUgaWqkb]cmdWRrE6gPC,gu62n4Yr9NqrQ_/c?3VE2lit^\U!5pOJ4tG#sHp+S+L=\rBrrB@Umm`Hgf%3fj"JN.IR,!V]2a`T"a!<m[r#,%cIh=j_phs:k+haJrbIiM#Si`m,No<1nIG$stVm4@h9[ou`#dM6odW+Vpg?7i`i4fbHO&jZsQWd=`cF3K!nEC`&=kgKE3H3FkPo*X<TDlFig[TL-cOBS9:%7;=,e$sb[tn7+PVcTF]or!]IV<EC4L5PL1LpTL4\,gMpbCm=U[_N%J9tYu9J1l"J3o"AbVKf4/d<7T"$H7uBCRVa?>CI6SabD5&=\S;Q@Bb;LIHRRjnga;0O-BAd4&[+\?`S1#Tkt`k&`qK-M1).p%#k+F#t_pWdGoKHVYSoO_U1_\$iNRL-N$%_=i/j"[OFOJcOX%p<H-+61OZ0i^gK!Ch@r:dI(PQ\W^sS>npM"Odq@apZ*<%JklS(M'0$)]N'0Pc`4=okPHkj8=;6FG)(*e>i>QNe[u"%2I8>lmQN;=L9LM8%[f5aG[uj6dTL.GrKq6\=Z5:dGes%qKCe]OR[rlpYhYab]:PFiIaXf"YdNuEYX>O-mG]-Nqbk9?,>4?j<eDe.'oX2f^uIQ8%$j`EC[mV+WH7"=D^V#FT>cdH3b=nZDJeO!=P%Oj(lbEni*buqi:6pElbH0QRuLe6"8G(G9jLLiLX5*YW'MZ_Zt=)]8-m*A#n<&"E-]WUo=Xk#i6/kTGc0NHL\t4n$.Q,[[3F4k6"iY&!Fog*KJS2g7puOd-NkL#IYlFKRYlO^o!t3Zgi*.?LTsA0I55.LT*ls\3i^i%o)Jft(?JBg#NZgK@#f7jZ_(atB>]%^`1+LD>MlNR+LSJ8;0W+>XUC8CXe&&lUl8gg;pg>ICZ/@5=Zf@IL23o?G\je$'>kI9ld4D0P`"T2PS1F\mC"c).cWW_N:erOf7uJ&Xm,63rr@lLh@8''/ap>H2QLu&b9U]V>rqJV&=$7_ZCm"X&Wt[p?2jo;R,RLVD/<FUAZ><?MuNcjNsbY4`)h7RoK't7=kgc:Fa9m!ZJF8>`@3ki8L"?\_Nm4&)",NTr[%@>!9$-ON=;k&)VEX.g@J,>_6T7(!::QfjlU+d#!5%qUHQp'&l^fWq"r,.T7K+-nP`W>XXuEPimW!*,Z71V&<-R_FN8/Oo%/%f365ujT:[St#5FD!*]EdjiVrl`lT.c&X)Hsf7ASFO`1L\41q(ghLlofCQZ,E<$kniM*pHM!<@7@crZBbbYY&q6jo3#u\Fn*np4Ml/LU92`:q>%4kq7+#H#5BbI5RhM=sO-EOP>E$;,lV])!R!F5i&VsHsrjrlTqo/FBc9DFPF/85s0%d*CpD["T%0Y!3AIM6fP9Tpm5(PB8*L*4Ct;P^D=3$,4N"=[?0YIp(BpsQ!,BneHDiU,fsUBOMHt6YJHhO>Ppk`J"Z'W'qUgEd7NJ&>"CRIO[uMt8%#\-2c)g;lcB8FkF<`qWCL:p!8#;jb"^QGnMB4'LOKr,"0>^ApJG9$(@u7/Heh1:ZN-,B?8o;^e`q/Tjcgh,6J%t%%YnVq>?bB%(#3LI_/gEV1h!Z`dBHT#E_!$$nXhl@Tno2T*ZL4grQBG`7"*H8p*]7s'kHJI@j#iVNXsra*nMt9:Q%FP]PhSapet&[1`B*4H?Pf1HpR_&Q>*T38uSnrjq,aaduZRic@:,@BZ?h]>!6eE*9=$@A*JD/a4`/2XMLc>?$TKbg!-H`g_>*[JesL[H4BlSU%K9c'B>!(+8B0g`#;phlKQofCM(/1a_@IpD4*a4@phY+h0BmZYEf=fO,SH.B49g.W--eN_7J\?8S`V7IBFETI("<oG0GUBgfJZ>gor'=clW:*/[Q%@?3%Hpj;,ATmB.=>S`Q#KUkp@ZeB&pTDJ*Fh5C8H=.T9/tn#<%-]Bjhh1T]oU5%r4K3$<uS!SfATF8C;8bD5I<i5=PV[&r&Kf]Bh.A:!^s?i)SGK*Cg6rA%NaKD.sQ#Nf=JIt9^F#DKf2AYn'pEbdT']Sr2$17?hCk%?3SYp:`,J<EG11S4UH1?uGXM_r[;7/.8'<MfAcZZSCWlgWf4QdXH-RRu?K91Ha.#T2VZR5o/J?65Ud8Z=qoh_@l#Hmd@(r(YUNpk6?jH[SB@<Kbp;]6UP1SLq!SN5cjV.2uNkPsGMMHj3L&g@'p+^C9ma:tKh_\ErjG(ejMV])m^@T^H&qSEBlp-\)[rI/a2bM$n]\ph/\\cQDjE[4Gk1jp)"T$]n"&bW,bQ-]sV,&)(LR:%1qWZSF)XX$*>ND`eYXC6p_P&jn?hS0GKQO..?r%FMNDMj+j$mQ8$BDJj]+j/7TY9k1;14P+m!\i^&Zp=!3RCKlUsb3fpgD95/j#gRo3RU-^,U3n3F]7!RgC],Q$qaK#*FaI&%db-N5FW.O.7F,;<N!#?kJp^+Q<U^Eh'C7i&WlO/a[8-rr*#DZ'[=CgGosaKp"HTo-/s]6-@KC@2^STpsL&Na>nTE`@4BLP>D\;8`..CfnT;Ln*eY"fr'?"H;6liqYOc2`"O#YmQQLd1$Ke#*3lVHd&jCR^)UTs2M#lUKF/*!a\ha`8-?V.lCLtl^B=js1RO&L]C%(=CX8>@^!E6:EgJpK'kr(PO&*bk<]hoC"hGGn1XZI:YO%F*_X@kHf^]gAl)Nc5!=,cEmciEm>pMrO3Fm2F/Od4KGhHjpLN)O/hIU>dWimNPc!'YsrB`\(6RLKp!+rrB(ob>bk#2*4SCC&6&"5Dq.2AA6L\c'ho(7G+e#@?(Tp9G*E:DT]0ocVg3bP1r](N26,YQB1Q#_ckrJU[an`Unbi2CtE:e6tP$iK>2F=\QMHQ</fmJ)6H+2pnGsN^)PODb<Ia4/OBa2+;ZQ5p,E421WD]`I78O=iLM2jn[F0.%t`5SJ6<0U7B7c?Y#lo?rN%TI9=YmW,]B8IS^IV%%fT6oq?u5jMKS;V;t6K72>oi^EdnM_&R3)R6PtmOOA0X.`*q1f!ROKDj/<;\>dW%YTlh/uInT5MALmYsmi21FnG`K?Fa3P^ZKf.HeQU>b%qVD:2<;#GO83VN:C5Vnal!4mK:RGf8U*EL%0Cr0F\`ZHY/0hT$S;S%md;C0(_8Vqql#H?P/JBr!-0k_iSDSerLlD)a$%?rbOuAL86Qf:cOc,pjC*nu]Xbl!hE2?ihJrEGC'ci;rr<W\?D[6bV1sP`Mg<YY<q?b>1l!KUgGmO:*HDPP$?;=k8Zf,iMXnKMmX5o0rr='QhECAqNjk\;Y+]?M$V"4ZIMaTs>6GZgOo4c+^Ks/%5O&;%#K==9H)!PWe7+ETDH",CHBpN0R=WKAZ\$q_DdO7(3:]YZfcDU>='6P6^ihDg!iWe6FWd6uJe%mer)icG*8pMDr[71ZafU"FBJ[#jEG(6==\Ff+"0B0l]8uZH#;*^T%utg-W-De.h'XW!:UeGIg11<tH-\dJ:'p!("KQft_S&++n\1?2/DRmsb'_V.N4(]$H:ua$SG*9_hVAOi_+l&K:Z=?*/VV.;)lC_k>!N4C/-3jS\"?EKS_<;]bPbH1mRM1#BVD:p!4G^.Jn.)!bQq_D60j\TPL[;pm2C8I8L+J:G#?Q@a+-tBb-0*9k<$G:EAMt)Jm8fpBW/6f#..IchgNcd/.U^%1WdgQE''+]r-KR(q^c#kl`'_6&D-Wc8h77H%iYDC1nP\2VdJqaNg&Bq-fSdVl]mb.XXa2,#[(^>50kc84(V2>OoY_]1R#7A5M=c-lbf&*\h1\5k^FB4-38:V<r.fh^q5i@!DesAR#dd*3?6rs&7:%fX"SibWdInCAYa]=ekLq:He#`kq3t2=eouFr=FSF-ngad(Q"D12$J@F%iTbm:fDZZ85A6Z%pik[tY&t800k`8rho?2dh!(-9X%jBuUl=^t,^cnu(!'>(^2MRC45l?.YLi^>F7UocBsms@Y<UD1nqnj!..%?iU4<S!U4<S;1J:.`Xp7+bGRHq/p:[QmqJD17Qho1K/u<NGk"DV/'d@69]-nflo4OZj_S,^jiE]C"(Kq:)T!)^LI3u'H_^(@>QgWUfbVFt2'BHVPEd&LeQJL.V]4@)@$+YV)/eC,V[-/Ds3#PS`Och^Br`NgYLhpn#Nbb,?D<$b@@qfS87"Mf;Up^R)a1n9-)8")9S#;t&p`&.hKt\RBpU\A&@RdnSU+<?Pp3EgE/n3V;<`rsRc[lH+SdQ3jQJJV3$fS"=^+&858b"*`]sUuYBV$ZKJnS[8*][_AF?`.6i8eEM6P\rcOb[1$h&5(F9"85rE-W=/5/0s^f2T2*q(.3HS&?8[c6QaNVotF]SD\<+J#LP2Pbl\"*f/mi$1N/VIh&k*h*X_fl<R$\6JcI'V<ms.Z[d(PB:7G)!a+e+"J#/1Eid#g%fpDD,)99Q9=dWFF*A(MeF$M[.E`J^Xg+)4<[F-'/e7"hAViS3YD=`Jk*?rZLi2=6_QlH_3rhU<`!5-"_laNC3>lso]4%^84>s[7pC]f3b7r%\(fQqR,S-8ba5fNDcVZUg`FNPp_u1'>+'R)6`?.\&g3GP+<d=t]H%6N<mbq7L$B>UF\M!dhVHmEin\)/HU(H$n/?YR>+YeLS,b>><])?p"Xff!IHP3t(,fPQY,F'+,]=XhJjk_f>dlA:WhS!E/'QVu6_ZWlCX=l-PWlc9!bbV]mjrXMPjCVl_I3,.a[?9I`%tA,>$YZ+Jd;?NfBY'e3D'6F)[^NfX>qZ!<ASD=dQA(!1+X@]EUm'<4-U*ZpHmA.$Lg.e^g)=3t9B$Nop9*S?28OqLLk\t72QfQnNk+i/9)?13q$T)4jdhZGMHOEu-?eIRc-A7Uj3rtJAQr9CNbDmbjqs]Mr]S0AT[#`-:hM%b_"s2Y1NKHmGAZgII\20LM`B#fHjfG!JaYH(bs';8Hi6F`fj8!"3fVDFdm:L+)/5mVZt/*<cX'@YnHZmK$@%cOH<5i=C`Y/Q8],9)f'7KtCueSGNtoMkO[rMlGrpXdjCB=:[EU]aTseb6A@S$p`=kq=jAV!P)9Ea=INk\*gN8Gn)L-pV'j-j5`.[aiHfqgd3jguY\Xi[gP-pFik^N]I,G=gLlTgA&2`bO2n_ILjalSuRl=f6M,ACe'0)JcP_'C*#>B\VTrZ12d0=j)'Y+H`qm:/&Ak#QnkCGl=c'FY!P"u:HGQoe@fV6./:9_66b3"E(Q-j9oS]-MrY\9%'mP!Gk-;mV3)Q1!R$fPXc)'EU8T*;'&no,b<2XkdkX'!^WNhm:X\XF)n+BJ=.LAt>u=qf0?[Rd,0G]Ekc!Or%IWEYet5KDk2bg]#Ou*mulP&QreV)O6$E\RQtYF0&[)c_t0O9EKa->Y+`YY!<iDE-iT$<-M0_;p1UghRh6P"1`[;HB4J>pE$_Kb?<<e.:+MtlYEJ0qrnO3ja)%Lnb7h$4_mJaVfkieDfZB%)e`:o!OV?-h3-Q<ILBh+9rM\ilOd%*.bh4m"G0D:F.AcRnSa%:h]HNuH7+Mc@FTCWN,Q0KOg6m1@-ZDJ0Op5taRhLB[FOUsA1;GDDfFWFXAZ)11Q:66;Em4/mFKs@IA/:<1D&D-GWOr7HB+T)R_M/#*7obU)/*@egA4Mf$!QXkAUEf2ro-S_gU9t8r5n#3FpJHUUl[MJ0M<2GjFkV?QGd9r!?dO2,ER4jE\YjgT[o00dq+eR9h*Ok@MMaQ;Fs"O)5`H+BkHW\Ds\K>[)t0E-=u&oN"EPA+#<irha>mj/%=s]H+j4Xm(;cY;q89=;WCE`3ejPPp8cm+eo.8Rjl6clP:E('JW\<LkAtOhnINDG"aI(PP?$,>ae%d;(qX"!qj8VA&`[9/N?nlh#jU?23$a*kp[_bH>J)C:`)/Y;&M(?pcQ"UA;:F*YFUM:*[cS@]N+,)uG2rT&6VmUCHA]F^^9!>p\\e-ni(&G!,&/d0C\AFfH#[XOmon0=k1)+n!9,G*3<4<?Ag(ACH%p:^)K-Jj(%A\mFZ?RI)dBft>@V5'p1C(@A+lsEO5/"@8qKUFr/M'DirH<$_0()?^0;b+Dt_0SKtj(j@06Xo\]ulpca`YK&R7aY;]LW:@CR%[E\IuQ;>H(hk-_f3GCJ_HGa%&-KD\e^U"Wi;mqW]$C2DgF.dD?u4Hm6/Di-u%/E#V]-^2WpDX;J[%9Vgt/Zt)0gVp)T2XpMkCBBdT]Q@OI+2sGnPFV<jRltC[e7Ojo9C$AmA,GL!b3ZeP+<ES)bYU1136[Kmqbo$4g7E?QD:g@iSo^$T>gdYV>dA97RS9iWG\4k2H7c:ZVd#rX9tX15gHOj."Qu(_,j-bMfd*0']JcV`3;=Fre$LVUrA&Y-d;A!RZY4J#\0QqjB\8u"QkGgD5$'>bY:[B6/N%;_q$_GuQM2!m\?&T/&3XtC\>I*El.8_:)uEcFY1Vl;4[A@^=:_APZpmrROU#d%-/q^PrY=sXOe^Rop('!K8c`LO"k<%u>;/d>No=O?7RfZINpQ\u\]e5I_!_TnhA#JaJJF^HgA$C_,1Z+!mcL,/pc=X'AF_N<%BRGMOn1O+RluQ#jbKA1rNb5&`Bm)X-Ka-9#T<)np$LJ1D+<21^<lTd-,'Bn1l;isN^:rFOp)ir[jtu;_Ck(Tb4,^h1uB!l?Lu('PRB[7HY1i12Yg`e18/Y+3<L/ZT"TI5S+.$)?Np5&`)c`sV.4p3W=3c9[gB-B`*$Ola1*D12DBUL3Ql%sNdG%n=L6OS4f-@]&[sL-;PU=OKdDt_4FFqn5(jRp3eS04gF<a?!/FGk+\3g_rO(tV3tOrQQIddT4VBRC*sq32)GNJ2n[&h*?-.S=+EC/>^,J8%p/M*=!Ul?<?4PE]1%t7fD3i0N6Mat_l83_`jii[bndh5Ogd*Ka@$W/[SDU^(m'#J`mB5BWO[_s^.^@#6i#\E::TR]&_$nfK5m26/@qd5h$k>9&3'Bc(S$q_><`.B<X`O2Kpik_'@oLmb/Ikpd2-IZBW(.o*Gn_&mm8_s2Ur"pQ9Ft1a&eEi8mWd(9rr@e&+R+2PL:q&/[aShkm?5cSCI&Vir4h'TUf*,XOgH*9i8bQC_CMR^/$[TZ?1F#lq29gq/e92h*<-$3Wjh]qRJ*$8^U.iAd3&jZq<P_F`X!I(cK5'+^5&goPg`>iL=0h\bj]P%[,1oJE+mrqg*>'UAroN&G;[<iMZPUYNm5%c_'_8+WQNlg(J*#i[MI`F30RO6Y&tk`_75b^WB&f*JuaKuK:MZrdD"4K[)eD']81<VZD.0D,%i2l"L&+MLVK^,1M-$WU:1pLE=tN%@4O;E6,jC\A!-SE:/[:hh:X<F7ZT\%0C8#_58Mu:QJ.@Y+G3+k(3VoP^:CY7-pRbUOsq-,Y"?b'H#3+6-c93p6%_Obg=A`1(,q,jBs&bF=I"n;1,B\SgZL,,8C&YH's7/:no(tHMW&W9d5YR+4[,Y4U-&6dDHbjK,(##Lbn@N=#98lX*08<BF.6F:kW:;bI^/B\_ReU%YA+k7>\<k>dRK(n>mVbhh-(5@NLPA&!M!\P:@>X54'Ks_o^-k>ZZpBM"TH?.d+M!-*p*@W!e@?k.KBTqmHMoaeSLO-+hY8rJ.CThis0H3F8jnn!8g/n;[0_/)3Q.mC1Vh*;pJ[n]*3.0c>kZ*R[_Jdfbi<?!"UngY-i&%D+2[[`Jc\nO.>Y(FW=$=Tn>)Gb9MU1,_@dIHjsTD#D0A.-UuPPFR-2?Ud6TGRbR,:YY,<ec,_2kATFS9!E)_PPFgRqRW+O%3eac)gIeB6\N'YK%/0m7lVbHnBcl%&>sc;>a-2nko5fk-kFSHHW2Is*ioO6(lW=%UHlK5%=sfGUBm1T#P8o_$-*F(g'];L^FY\f_Z8X&(ZN>)@H-]9]r&4',LNB.p>%q%2f6Sa-RXLF)DF"sl'J_'UN^FZ5jg&n_S<?Y;e0$=M7k.4YalZ)33pq7/:sK)(W8>'0e9<#Jf28ohrrA*qW,=Zr!32,>9P:9#iVAO<DPZ?ph8>Lap+s?]i@R.2Fr'dTXh%fl_fZ.B`qt;X@Zb2\^/bJn:e/#5a;@%3N.(j';oeaAg9.o'Fu;@>EG'?8V.qqi%<HHH(hN97)j'0k4Thq7bhKf5m?[`Talg_+Zt<.h`X3,cZg#Qogf+A[du;B[^U5i2h5TQik1tX!)<X!sp!"d379Mc<YOW]rc(B[G(REXp$$;P^]3R/`F@_ig6#,@G`"Y-;gI?L\UHGu'>Pp_4XbVYJ=FbcZ(QkPZQ;$$\QEcM]n!b`;IVePH;k9:u908!e(p;e_AGacMMHP5F+<OJb1%i4@+d]sO6+Ei;167f4,Hjt,a1/#.2S!%&V%iPOG[&%rB7fbKI3V1eO&+54BcUTBE?!u#aR,-^q46?%F->&^4q,m,]O?*FG\r&u2jU`%:NZ.um*Nc,Ou3EOU4U[0TOb;T^3*LT[!.L1l5")_i"?)uJ9^7K(a#FmZo4amL&fh%.@br#1'-NM(u*A"7o)uZB!iYF`>SS0AU1FmRa'&c9iAhG@#B%WTIdfaQic]q$&LW%`]E[2^*`?hS`:_+o1%;J+k1ULfSim4F/^Z>OuOgP3';UMGImX9Ujm%5FUJ)B*_p5Jc-A&QSpHEgU7E=l][A?NcP+CiM,dQl,nEHIe)#i6[u`#7HQ58)IKt*f_Ub0pX;Z0F0l'h)A(9Sj/nVkemLT`,:F+6+b6lNQ%M%KEP"`Rspbh$FLO,2Oq@1-VGI##mZ<ZZ2[l;b2$G``8dn8@+F27'[a!Ws\0mdeA"V\gXE*<emIdghmYHJr9;9u:Fg;ank?<b;eUNC>uWhIHQJknO"k>pkBhX>m1PqsAr4p9=s'UR"?5`iFLG:oS;-=*F=i^O@%=dY_%)gUHbq4mHfiBN+s-CY[M_`CS)\D,m)pJT^N_HR"nRO;,C7R:@952>e&gR<)H,6#rso3Z0!o9XN9`nV!oS;_dT<PLRMlC6CPWF]?*5fQ@gjF1R&ALP9+].gPCi30iupcAET_Kn.qRnE6.SK^P6Z26E&nQ];R&kSK==Zjsq?:)Vh(G=I!aj.YOrZ5c<%<RBR]K^;BQ4H(59BJ'p:HZt1]X#]J=l"mC=RpJq3U$IsDrn%qnSDm_WnYN#$tY"^jE'`=Zo[oKEGR6Oe86M@,9g*X8eLXcOE(1krr@HX=raFgo![mH,]Z(&pb1U`+6qGRY-f"ceDc9g2;XUFF($?@E_I+5V$5j0dN+=0o:K&8?X!46i@Sg!7"AF`V13#@f%.1kpG1Dt*)2C3,`0>lS/eSBE?pakDXJ\!o]qu"[RG[]/Z8O@8X.9MpjpJ*q2\^*C:7$m/b34P]orH>EjD['JoD!3j/j<Lhm#;KCn]fP$J9SN5h!)7*nhPR0$5CW>K!Xo8]`*]'?Me#8L1`9c?$<ha)Mg-?HH(B`SR(d*QuJJe8dSD'dZMbeWt745I3D2T5O^p!V6\TMNZ2,PltLe"b8e5J/KU_Eul:J4Ipr@=IGseQlXS5Drn8r%XJ=Qrr<?1ppVoEl*;Fo5Wc64IT@qC3UPSU^Ii6%bc)jc/&pL$.WQAGJe!*:q:5@V64PE5CNIL5m@IP%*br9kB?5(Z_dj>5cQ:#fE]H-!]i.7>D'Mi49>('NJXefUg,Euk,GoEN3?4-+kG,=AIUa0&AbfDDTPk!g%k_k?SOR\4ppY_DXj`dZ4(78%QA@4;kA\5tI)h7q:L9ruq4%X,d]Fs#pG)?k=@*>\GW3Z])>K!**^&r\_TrIqM\YuBm4PeNSPrk"qe`\u:onZB`="TWUgk`j5#A.u"-L=$_+tVeX2(>CDa"eYXY`]JA^UdrV!C2bdmf^fa7b4I8E[HP.#]1!D?jq]a8>j7qaL9!_*8FBF5^oL(3oT5m]!@(G;IR<Y(qIDI#1>=1,oIEO"2E5F1FUAh3')9rK-+02=JPW'i1N=58&*7(IOua(9]ZWe7G?F<MEAu&%EBq!8o=#bb'COU\/I^CAW.gJ*C569A65t]Dhk:Zp)a/MCZP,&>G%1!2>?!!3TPcOCn9-iaA2#p3cfLD219pDh#Rp4\\c)ZtMQjU>K[//Lju]6L[Om^=N_0#7'efOm353RbSFE[BC(XB;fO9-h.q&epKPB^6FPUf\CtQBVmc=%Eco5`m3\+`aV>q_drS6O+KJQUARm=HtBF)QI['kjD)$c&_gPFOt1<MMAX`BEDT2SbfU-6j,qN&?Mk,X0=<(;I7mL@V2E\Q6H!.i[_M]'d2A'KOuQ=#Uh9cibD3X3r$7>(f,Ibpf<nBa?/5Z&O7kuU;Vl6j!^Y,[3Pc^,h^uI>e;HnJ?=nSj.!urDH[*2'U-X/a/NZPSjFYPAkBT:8aH?geZSO=p^=#Tpa<s2tr,TsM1qE5f$u&n2SaeHU;LLn*p3=]'[uFOn-##^Xn[d[YF='H8Z:k->i6MU2p`Dtd9@MYo&RFL=jk<9O@Mt`-R$(*[-TuK+a<d6ki-S+H'^ECTH"=P:2$d^!5ADM)MVUiN,YW^h/D9^l8He+]o>VDj]6#E_Zfh:1$SMV[.e"O<["=U8.(t=mhW:&-es=<gD=,"(5i4?[GRP:hm,@f#42UhAKtKeB^3qq9MUpfiL.Etqh72=@[ol?ao1nY_,aKuQA'*W::>8S>,Gj)Y&N&4=WIL\tR8'Q:F`G"HgWYVrG5hOYgj'QrITOR5/A;hn56lr9>s@fOSQA^+.2iR2obm\Ki/N?V&V+q]!e@^`!C7t5^&(4KY@$Vll<91+08<YbS)IRiLj'\XdVUl4`GD92L.j9:F@G!*EBAso0:_DkK1VEipq/,[l&"F0=A.XUFZh]u\lOE]nOmk@a,q:PT:NaQ3*"$I-[2V)^);\oT2W@Q-/GS-$ep>HrSk@"W#LBI.YKfZ_9(t6h1O``KNA(+nPtX+;d\*4D*lM]$r(.kKhtPj/#rY@aQ\>t(u-&f29g4_Vj_j+^uN?k?86@71[EcWSYb"Rhe7:gSko2&EgMgq<EjR!M[iNBa>n(o%VaX8N'89WgVoN'\t6/.,W>Lab9&lJ.m%GhA3OqTo/elQGeSWSk"eb'rX-]F1.],(f&2^<BPb(4CFUd_;1;?ijDoF,$0jdr3FL8#?N]rtS)X9fTrR>-GH2AAFuiV%?+&TZN\D>DATEY/g3HX?k:@]V;+mB_?i%8-$^TNg0n"HsZ(gR\K\B;<11/^ej(!6'g9;/)+(sHSbALkE#g,@)iO9mbffh&pDUcB9k2IaDGcKSbUH:krm$AT$q>TeXWTj[,UL0AG^6a+j.$FI.LJ!k3T'&V$m?YoW<SDZ`a^n@?baYiTAG7[`j0&R(j5eZ4T'H2H3b@ks(ADuM"HZ6U<"O(p.jU!<*1jf^dj`:;/!T#-BPi5iRa4:hQFD5n1nAf5D*cPiRB</[-3oi0W-LM4c8"o3ItbBqGJn:e'B"(dA@mjd&DaOHXR'ikm\SVjVN&f21<oCX)frXgg%k72H`)Y5*nt@SS/RpOL%_LF-&U?_h<aLRaKg)^L`Dod%WW;4=LKQSn7thM:%Ne9p;Um-?4C>@ZZ-olLr/-2b7L_tj[eJ'60,^KUgTJ!&E<)fjVfHDjPCf`n7C*N^)Do+nSFY3Tqo*;Be6A3Lrtf1_9(Eh0?ft\]h[PKG5a;e^6.?%?bs>2LEa4VFW6<8f"p=MrS2^X;@oaL(lbO%D:g+EN1K#o=J#i*BfmPeiVV;GDrT8*96l"LXD[-lNO"Bsns.2p_<mcjgS42h_O0u?@NA*@f/9`Cgfe]7rN14Q,%;,P77%eQ(!?ZsEKc]$c;RVb=r1\d]KL%BqPJlTK;[LS_KDi&O&ERgg;>$KOPe=GH*??A:;R$*+8*;dESn%k=5k6cVo;7#KtE]=ILo.sXmH^3fm>!Z4j*2O'g!S%0sm*ahh1ehQc!SX34.o/QKgEXodR:*R*=X(dn"&:+$\Oj,`B%mY;tcgbnIoORSJR8Bc22h^1lHpBn0j,P&=RsOthPi";ASrEL,/+>jb1$LuduLD;L&B8+DpCf;u?8jjf^7_c2A;@%h/"V*DX\jqQulaQGcBccqf]i892o'(N`SX'K@@NAWk'=L8lg>5+QO5FBX;`nS7OWORH`(scL+\"S%niPh^Moij"9?XDRF6);>l[$/_Pb8`8RNLL0=b:k4&OEj';G;XC07`hHQ4&6K)RXUTNc#Is(>$b[h@U(a@<9;M4\_Iq(Ghnmuq,K&r:=]_@qAqeuGb[^Z>>3WGG@]PUdc0b3gdnUYI.eBB)U>?)jiZNL)i+rR`umR!R\,Bu&Z*NtE@Y7/G+JlMSednn0WH(WA.h)d\AX(mCpOaR!_L>%jUZn6H*rI3PUF_NIq+CEF)Nq5jE;r&\pW7QE^iMXcK_tG_]:)@9*mf2F+5/J6g314S'4Np7V-O"S>tac-S9j4A'&R4=qUR[?e=qhaKNk<j*Xepf>G0)_X#HAf)@Y:h)`DI;W#FLEApe@W#s;thFrf/NZ"3)pc/KFf^[RPF_e14p6r?rl*ku(]p__RC8>%$r2nD+\JnIo$o'd&W8X3f_+c!Br<@[k=k#PnA.hDkp:aI<,^GB"`cj7)Od0Br0u:sbk^&PWC#XOV9fl5aC-$5!]16iV#[,]_d"^Lu:TmXAXutt%^>k+43/G9]pf>\t7\<>*D&W8ri[]g<mI!KuDDsD!g#V";d//WIg"]lC432k0iNA)I5K#bu?/0Z?>MVSm8T`kZP=Hl!&XS(>q8Pi135JEFa0+?-Z-YZH=khb8/bb*EXa<gO,&9n7:q[K,G3iaZO."Ni^tr:T\^)i'3[_g0m(IRZ@`u^DWOKLOI6m4#?u6p[.*[JFl.S\Er\"3N2YGAGigu4\[]csoILEC/B%4I$@A<#\;>AH-mS-kj?8:NBegYY0g_V;8,f"4QGWa3PK9O&k`?#oEZopA.2PHr2[\?k5P]0C'2Kh2:4/a9n$"Cdl[dUeKQhCe?L&+fN*Z9\Ol^tOtf2CM\c0)j0+a3hLT:;4;Gm/K=:m-+ZqsT;dG.DJLB9GoBIh<VsFZm+!%[!J6BYe^'@m7s1Xo)DG]O^$:XoAAF'G^G)0DKI$A#OY<>e$-9p\Km7G_/nU`G7'9=?]Ichf-np/6<1S&BCsBSe$P+0RQ09$u%cXPA6OTL5).](9Ggn\s?QT6S+/XY^M'-4.-$;O!2?'g\`Y^X+(Z6l5%Pfgr4\a/`Zf'[tc^B0=NK]9U!<ck9oD0Aq,J[?.Oeih*/_Z^='/@W,ZONC%iQaA<1aeI)M-1F3%bB,\3!=4O1<F-KE_Sp%\nG;)Xu>piGDAHG6Y]h*&35p1&)+Rha"[A0<*7@Z7e;88OfEin<VS2jF<eSh\\iM]0G)M/Mu.&_VYMgrC[]`J`"+cATBEJ>gNrN9=[jr5GN)Z1*B;eoY1u_L6&pe4ut3rr?b>:O$Gt`'YMr0EZ/_YXmI^E9F/IG?(g@EmM\XLPP>%oqJ'QTC(4SD(/gNjk.B-^1b[""EV[kfaXHa'u+(O=mVR8g4+Zq2#'(Zig<^0hBfUY7o1+hU"OO"Np:4]@K'h9`,%Mda<*<Zr?m<ua73Bn?E*r)#olfKN>kXAVmXuH'5h"5+#6F]De3g,QoP-IJb'Y*b<LTi7Ek!2m^K4]3]gTgIia^ukn]F<ZH8@=G8Sl_OJMUNj:Yg<`SV0!nQ)o5X21b"\gFV!+5&j6V9Z?h/1*f6X:A6m8R_cN3Q])?L/P&Vg3^U+)N1o`0YSW3_r6Z54t6!(T6?3fV6->lQ@a%Dc?Z!MBU@j,+V:^Al19p!@UIFYC#RD59RM!Q#1lK:jlW\K?-d"$T"ShhBb$\l86m7+bRO^fgJi2"i9hQ_]>8q*Z1)U]q\8VdG;lTM]@8GYo.DZM+9sMpge^eh4!*IRfCWD\`MI?2VP9D$=nQAuk?`+1,=oX9=R?r35i\!a-'F]p])./Ef^j"lGX"^nL#\d@5Dg15flXbKdd8T(IV@_o>K"iCY2Tg]c>l](8-=Smq!D-VZE^$&n6AjLUYuKk9r"L\>SASUp6cObD>_:!-pqMom2uNd,L#gf'mr!InHQ4drLU3lpjZ5.1preP!(a\#2fTf?"?C!B]@a=1\1u(N8!?^C@A?t>2AUK1P"Om5*F`fmPe?asa!*a8c+B6(^uOPuVfhl@/RQ]*e4sN32thEiWq_cWd-Y_XI0*Oaef?O30bJI55A60&o,GkNbe8Jq4,45Ir;4GHIq/CCf!Tc#4)gqK`AW^$ib55VD(VuCQcdVI;n.coN3PH9^m!Y<3T03T+'I0;90$MhX32O-Z,\$YSj9<'f^S&)NpX`ZEQ:uP(S:mgD/WdmeL&hS.BKopf(S,tMX7IIdj[V;PTQ;Z;8Bt0BD@B_Ws(G1<e/XYIh5D^_*8jn]O=8,Rq,F5RJtNNZiUQt8GR4F?^2c5o9oB3#)R?Z:E)s*kgF8CS`nPpXWgD=*b6(M=cY61^2@FddL;4A5%"J4Cd5&sVr7Q4ipC'!_l7C:p6ql30D)jqh7!01!E;-5IcprZ"i+p_K=QWle\3!dhB[k`9B+Pj`(LK`f$\Aah5"_J6JKf$\_Y:GoJo#$26!CdY2A@;)=k,WmIYCsr'J.mA&352o)3\//R))+i/C#OL/B0;2IJkX%"at"%XO9sf(eRkgC(b:fit":9,kVRC!l6i95^pdg+R#eh8\;M'e1Gg5X@OZ;tC%mH@4TWJ$cW*2;<$bCK<AQ<qc#f$Oa6#bT\1)i.HX(><J&>GPS^iRLb,=FF!P+Mg6*.263%VSB(f#2_#pMk8P.;(^$K"Ea(J#.t?m]oI6]nig7TfGba8B_eh`k=W6#c7F\K84)g?5$Si5$_]Y6^ai?O("g7bENGl1B&>ZT_f'TVHLI/thI-O3c@r^*FppYGP/Bbe]3d&c(oIDF$CK%LQdbX*8[4=>4k,M"(-3Fm_*Z/i^^fC9b41_U!pfc:c^)s\ce*\NrK:-8[RR8X8&j$0CQS$L'8aDoCoua)*B&W]'>Z9p4X'EoKBNJOK-([c?Dmf&=)8+C/P=pDtR3bldG(C38"RpFkEcUl\I6UHU^+OZ=H2J%7M5Q89[gT<(/[:>b&1IU\P,"#IahT(/[K.cMSuHM`XYsOB.H9nDQW0/B(*7M>Ql[s(iR'TT\Ltc^nX`4!IX9o1WXfqPlT0NQ24J;uDPOhR[B[9#m*c[\rr<'FKu(n),<5m`2,d:>UA]DE5$P]r)hUo6DDd)Q0#m,Mf2qKJfnW[`MQ3a:&XW)8o0D"Rg]DM#G"2Gf^"(_^4f8"<_YSu+V/:.LgdCT=HW\pZZ&.p91gPDB4%eo'5BZ^JrkC,(9f@>kBOTCC>`E9=K&0V,h'u$"G84T>1$s/f@-(q^E@6.]r'/ZuXW#V\QasSt<Z:,Kfb6rk3=/ADqQ7\q^%*tkSb4JsV/CgVqQn.),5C1jnE7b<\Vg4MjR>id<qb*&nP7KeH&<'R%A]rW#uD@t"hJ4UrD1Bo-+`U\hC$fpU#JiSrr?ZI%$KkaC%hKCaYJ:M"Ysq&_:0K\IM:gE"b`JHTm/@hdl]jAVSM?ZcVo1KMn*-+`jg<>=i1l$>VQ3un/%:KGeI&6Y*F/.RH<c2XDuL^_56&b2f#a"[6ggK-t`:bQ%n7`+c%E3+j!cDg:pGS%T`"9Hq;[tnOJ,']$R@?oa:dAX//N!SBEHk11[_%Ws0^03=KpIm^?34l/hFENVAG$rr@%gic\Ij#oF;@d/]9.I)Kl-c^\rJRI?I60k1C4Njac@X^9o,%1?es<",`OnW-rS4mR>o7CVdKK;RnA;i.TXi7a,bio>V-2L9ClHB*Dmk?P/<Umc4#^j\(e7+:,iJT5fIrP@!2*?5l=2UM9>40,i%2[T%53OTu2<pqj:cgN_REr'^2IOn^F-\Ef:jh96!'X1cW/\(@=0uK23l@9Hn%QP\m!RK*X?5rCaNe0,&[q<=7<4R@d%.5C(E8iU6`OUso,6s`KY?0dli4Y":UpYu:[G<0#1utl4XRDB1n-K+h((JX#!:kD?PF(1.AP"sfVtJCg,Fa<YZbQ:7HSiJJmX.LO-C,jj8Zdkapk=_<q8pd28IAQ2f]R3/F#q@[m1p4kYMs9(a+(=.d!0KqdD[c#d;;`C_8]FXQ:9`@73`%\+6X4GG\S6L;7k@VnZO=i+b:r)R':QK"\)jdNcO4Wn+r65D;ZEm568NOV0e-V3oUHURRs:cEHGc2nm$'E3Vh`JD8;<1J)Z:7K$gdfqWp:*QFpe)%iT\6ln,.D9*nc\]b,*4d0<*O0>@i$PEI`<*I9Ytb@dVqMo6BpC"=UaL\g_TAZ%n5NJhXPb)/tMj]?n32K4fN!`(A=I*^[HB8jJ0Dr^it!<3&91HqpeChADM/hUrf`:GY(P$OI9(!.Tdc:?aTff#H0,JDMMZaoTY[ri7,B=+)pJ<BtiTKFc\jVTNT3R1,k>Kj[$'K&RP6b>JDq[UV1NOJfko%3jQ7_=QV[('8QcQrMj@[YtkD`C)">cIO%YZPFg-+u7TIMS+H!6#Q9>-'H'/&N:Kl3C+IZYM7A3.Y.3B$)>Y+TMP$NX0I1GpgF$7'ka]f!-R1pT&Wf[O5"!k(WAW;LV&'M<$q6:Wg`HAV4%6IKeA=qGs5(2Q*XPf".%0F5<YVk?cqO!:gecYnXDKO5]<XLHVK*N&c$kF5W@RGo)'B'>ZSnACo;c>&!O?-&UNNHmn0)(#\L1PLL#FaaZj_*sUqq?6@S6S_g2mWlV<P>j>"b0a1Y?b+)iZO'XgupR?K>jR18\lUsY]+@aa2:.l&?)t/p1a1k@S*BO%cIo/j-9o!fQ?]H%#M4s^@i9uMO"+s;;D>o0)Ff!l<C?JHOeaDD+0cr:[g%M2?5R:pHNPKZ[g[JiHnXkhj4)81:Hs<H3rXN&;-1L>jiVS$l0CED,m367^/gQFb&fF$VJ\[DY3QlP+a6\TNQXA6[n+@1t7s00&,KhpgG<2'B]0$<#ptN9!SE/k,n.3;f!dlWNY&ur:kX.nS\VNO.Z!>N-cp%E(1S<[fpH7V#Rm)n@VsLsCf%Y\jr=3BD);QOaW1o1-3Wb0eTE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TE:!!TF_(U~>
endstream
endobj
14 0 obj
<<
/Type/Page
/Parent 2 0 R
/MediaBox[ 0 0 595.276 841.89 ]
/Contents 11 0 R
>>
endobj
15 0 obj
[
750 750 278 278 352 555 555 885 668 188 330 330 390 585 278 330 
278 278 555 555 555 555 555 555 555 555 555 555 278 278 585 585 
585 555 1012 668 668 720 720 668 608 772 720 278 502 668 555 825 
720 772 668 772 720 668 608 720 668 960 668 668 608 278 278 278 
465 555 330 555 555 502 555 555 278 555 555 225 225 502 225 825 
555 555 555 555 330 502 278 555 502 720 502 502 465 330 262 330 
585 750 555 750 225 555 308 998 555 555 330 998 668 330 998 750 
608 750 750 210 202 330 315 352 555 998 322 998 502 330 945 750 
465 668 278 330 555 555 548 555 262 555 330 735 368 555 585 330 
735 548 398 548 330 345 330 540 532 330 330 345 368 555 832 832 
832 608 668 668 668 668 668 668 998 720 668 668 668 668 278 278 
278 278 720 720 772 772 772 772 772 585 772 720 720 720 720 668 
668 608 555 555 555 555 555 555 885 502 555 555 555 555 278 278 
278 278 555 555 555 555 555 555 555 548 608 555 555 555 555 502 
]
endobj
16 0 obj
<<
/Type/FontDescriptor
/FontName/Arial
/Ascent 892
/Descent -218
/ItalicAngle -12
/CapHeight 892
/Flags 96
/FontBBox[0 0 0 0]
>>
endobj
17 0 obj
<<
/Type/Font
/Subtype/TrueType
/Name/F2
/BaseFont/Arial,Italic
/Encoding/WinAnsiEncoding
/FirstChar 30
/LastChar 255
/Widths 15 0 R
/FontDescriptor 16 0 R
>>
endobj
18 0 obj
<<
/Length 12539
>>
stream
1 1 1 rg
380.976 737.575 182.835 38.268 re f
BT
/F0 10 Tf
0 0 0 rg
382.11 765.784 Td
(Paciente: ) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
426.614 765.484 Td
(Dña. MARIA BELIO BERGUA) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
382.11 753.878 Td
(Análisis: 4580   - 11/Jun/2019 -) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
382.11 743.758 Td
(Página ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
409.606 743.758 Td
(2 de ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
427.748 743.758 Td
(5) Tj
ET
BT
/F1 14 Tf
0 0 0 rg
221.102 699.431 Td
(ANALISIS DE SANGRE) Tj
ET
BT
/F1 12 Tf
0 0 0 rg
29.764 672.363 Td
(HEMATOLOGIA) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
29.764 647.846 Td
(HEMOGRAMA) Tj
ET
0.867 0.867 0.867 rg
31.465 615.969 194.74 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 620.633 Td
( Prueba ) Tj
ET
0.867 0.867 0.867 rg
227.906 615.969 84.189 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
255.969 620.633 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
313.795 615.969 68.031 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
315.496 620.633 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
383.528 615.969 180.567 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
385.228 620.633 Td
( Valores de referencia ) Tj
ET
1 1 1 rg
31.465 598.677 194.74 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 603.642 Td
( Leucocitos ) Tj
ET
1 1 1 rg
227.906 598.677 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
284.598 603.642 Td
( 6.54 ) Tj
ET
1 1 1 rg
313.795 598.677 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
315.496 603.642 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
318.331 605.427 Td
(10³ / mm³) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
353.197 603.642 Td
( ) Tj
ET
1 1 1 rg
383.528 598.677 180.567 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
385.228 605.427 Td
(4.00 - 11.00) Tj
ET
1 1 1 rg
31.465 581.386 194.74 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 586.351 Td
( Hematíes ) Tj
ET
1 1 1 rg
227.906 581.386 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
284.598 586.351 Td
( 4.54 ) Tj
ET
1 1 1 rg
313.795 581.386 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
315.496 586.351 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
318.331 588.136 Td
(/µL) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
329.669 586.351 Td
( ) Tj
ET
1 1 1 rg
383.528 581.386 180.567 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
385.228 588.136 Td
(4.20 - 5.40) Tj
ET
1 1 1 rg
31.465 564.094 194.74 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 569.059 Td
( Hemoglobina ) Tj
ET
1 1 1 rg
227.906 564.094 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
279.213 569.059 Td
( 13.40 ) Tj
ET
1 1 1 rg
313.795 564.094 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
315.496 569.059 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
318.331 570.844 Td
(g/dL) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
334.205 569.059 Td
( ) Tj
ET
1 1 1 rg
383.528 564.094 180.567 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
385.228 570.844 Td
(12 - 16) Tj
ET
1 1 1 rg
31.465 546.803 194.74 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 551.768 Td
( Hematocrito ) Tj
ET
1 1 1 rg
227.906 546.803 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
279.213 551.768 Td
( 41.00 ) Tj
ET
1 1 1 rg
313.795 546.803 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
315.496 551.768 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
318.331 553.553 Td
(%) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
325.417 551.768 Td
( ) Tj
ET
1 1 1 rg
383.528 546.803 180.567 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
385.228 553.553 Td
(37 - 47) Tj
ET
1 1 1 rg
31.465 529.512 194.74 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 534.477 Td
( VCM ) Tj
ET
1 1 1 rg
227.906 529.512 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
284.598 534.477 Td
( 90.3 ) Tj
ET
1 1 1 rg
313.795 529.512 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
315.496 534.477 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
318.331 536.262 Td
(µ) Tj
ET
BT
/F0 4 Tf
0 0 0 rg
322.866 539.265 Td
(3) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
325.134 534.477 Td
( ) Tj
ET
1 1 1 rg
383.528 529.512 180.567 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
385.228 536.262 Td
(80 - 96) Tj
ET
1 1 1 rg
31.465 512.22 194.74 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 517.185 Td
( HCM ) Tj
ET
1 1 1 rg
227.906 512.22 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
284.598 517.185 Td
( 29.5 ) Tj
ET
1 1 1 rg
313.795 512.22 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
315.496 517.185 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
318.331 518.97 Td
(pg) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
327.402 517.185 Td
( ) Tj
ET
1 1 1 rg
383.528 512.22 180.567 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
385.228 518.97 Td
(27 - 33) Tj
ET
1 1 1 rg
31.465 494.929 194.74 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 499.894 Td
( CMHC ) Tj
ET
1 1 1 rg
227.906 494.929 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
284.598 499.894 Td
( 32.7 ) Tj
ET
1 1 1 rg
313.795 494.929 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
315.496 499.894 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
318.331 501.679 Td
(%) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
325.417 499.894 Td
( ) Tj
ET
1 1 1 rg
383.528 494.929 180.567 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
385.228 501.679 Td
(33 - 37) Tj
ET
1 1 1 rg
31.465 477.638 194.74 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 482.603 Td
( Plaquetas ) Tj
ET
1 1 1 rg
227.906 477.638 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
273.543 482.603 Td
( 216.00 ) Tj
ET
1 1 1 rg
313.795 477.638 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
315.496 482.603 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
318.331 484.388 Td
(/µL) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
329.669 482.603 Td
( ) Tj
ET
1 1 1 rg
383.528 477.638 180.567 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
385.228 484.388 Td
(130 - 450) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
29.764 466.995 Td
(FORMULA LEUCOCITARIA) Tj
ET
0.867 0.867 0.867 rg
31.465 435.118 96.661 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 439.783 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
129.827 435.118 93.26 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
148.819 439.783 Td
( Valor Relativo ) Tj
ET
0.867 0.867 0.867 rg
224.787 435.118 66.614 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
226.488 439.783 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
293.102 435.118 136.063 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
294.803 439.783 Td
( Valores de referencia ) Tj
ET
0.867 0.867 0.867 rg
430.866 435.118 64.063 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
444.189 439.783 Td
( Absoluto ) Tj
ET
0.867 0.867 0.867 rg
496.63 435.118 66.614 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
498.331 439.783 Td
( Unidades ) Tj
ET
1 1 1 rg
31.465 417.827 96.661 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 422.792 Td
( Neutrófilos ) Tj
ET
1 1 1 rg
129.827 417.827 93.26 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
190.205 422.792 Td
( 52.50 ) Tj
ET
1 1 1 rg
224.787 417.827 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
226.488 422.792 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
229.323 424.577 Td
(%) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
236.409 422.792 Td
( ) Tj
ET
1 1 1 rg
293.102 417.827 136.063 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
294.803 424.577 Td
(35 - 70) Tj
ET
1 1 1 rg
430.866 417.827 64.063 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
467.433 422.792 Td
( 3.43 ) Tj
ET
1 1 1 rg
496.63 417.827 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
498.331 422.792 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
501.165 424.577 Td
(10³ / mm³) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
536.031 422.792 Td
( ) Tj
ET
1 1 1 rg
31.465 400.535 96.661 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 405.5 Td
( Linfocitos ) Tj
ET
1 1 1 rg
129.827 400.535 93.26 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
190.205 405.5 Td
( 38.60 ) Tj
ET
1 1 1 rg
224.787 400.535 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
226.488 405.5 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
229.323 407.285 Td
(%) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
236.409 405.5 Td
( ) Tj
ET
1 1 1 rg
293.102 400.535 136.063 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
294.803 407.285 Td
(16 - 45) Tj
ET
1 1 1 rg
430.866 400.535 64.063 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
467.433 405.5 Td
( 2.52 ) Tj
ET
1 1 1 rg
496.63 400.535 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
498.331 405.5 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
501.165 407.285 Td
(10³ / mm³) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
536.031 405.5 Td
( ) Tj
ET
1 1 1 rg
31.465 383.244 96.661 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 388.209 Td
( Monocitos ) Tj
ET
1 1 1 rg
129.827 383.244 93.26 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
195.591 388.209 Td
( 6.58 ) Tj
ET
1 1 1 rg
224.787 383.244 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
226.488 388.209 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
229.323 389.994 Td
(%) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
236.409 388.209 Td
( ) Tj
ET
1 1 1 rg
293.102 383.244 136.063 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
294.803 389.994 Td
(Inf. 12) Tj
ET
1 1 1 rg
430.866 383.244 64.063 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
467.433 388.209 Td
( 0.43 ) Tj
ET
1 1 1 rg
496.63 383.244 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
498.331 388.209 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
501.165 389.994 Td
(10³ / mm³) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
536.031 388.209 Td
( ) Tj
ET
1 1 1 rg
31.465 365.953 96.661 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 370.918 Td
( Eosinófilos ) Tj
ET
1 1 1 rg
129.827 365.953 93.26 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
195.591 370.918 Td
( 1.17 ) Tj
ET
1 1 1 rg
224.787 365.953 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
226.488 370.918 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
229.323 372.703 Td
(%) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
236.409 370.918 Td
( ) Tj
ET
1 1 1 rg
293.102 365.953 136.063 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
294.803 372.703 Td
(Inf. 5) Tj
ET
1 1 1 rg
430.866 365.953 64.063 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
467.433 370.918 Td
( 0.08 ) Tj
ET
1 1 1 rg
496.63 365.953 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
498.331 370.918 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
501.165 372.703 Td
(10³ / mm³) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
536.031 370.918 Td
( ) Tj
ET
1 1 1 rg
31.465 348.661 96.661 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 353.626 Td
( Basófilos ) Tj
ET
1 1 1 rg
129.827 348.661 93.26 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
195.591 353.626 Td
( 1.08 ) Tj
ET
1 1 1 rg
224.787 348.661 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
226.488 353.626 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
229.323 355.411 Td
(%) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
236.409 353.626 Td
( ) Tj
ET
1 1 1 rg
293.102 348.661 136.063 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
294.803 355.411 Td
(Inf. 1.5) Tj
ET
1 1 1 rg
430.866 348.661 64.063 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
467.433 353.626 Td
( 0.07 ) Tj
ET
1 1 1 rg
496.63 348.661 66.614 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
498.331 353.626 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
501.165 355.411 Td
(10³ / mm³) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
536.031 353.626 Td
( ) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
29.764 338.019 Td
(VELOCIDAD DE SEDIMENTACION) Tj
ET
0.867 0.867 0.867 rg
31.465 306.142 221.102 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 310.806 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
254.268 306.142 84.189 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
282.331 310.806 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
340.157 306.142 57.543 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
341.858 310.806 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
399.402 306.142 164.693 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
401.102 310.806 Td
( Valores de referencia ) Tj
ET
1 1 1 rg
31.465 288.85 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 293.815 Td
( Velocidad Sedimentación Globular 1ª Hora ) Tj
ET
1 1 1 rg
254.268 288.85 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
324.85 293.815 Td
( 2 ) Tj
ET
1 1 1 rg
340.157 288.85 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 293.815 Td
( mm ) Tj
ET
1 1 1 rg
399.402 288.85 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 295.6 Td
(Inf. 15) Tj
ET
BT
/F1 12 Tf
0 0 0 rg
29.764 276.363 Td
(HEMOSTASIA) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
29.764 251.846 Td
(Estudio Vía Extrínseca) Tj
ET
0.867 0.867 0.867 rg
31.465 219.969 221.102 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 224.633 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
254.268 219.969 84.189 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
282.331 224.633 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
340.157 219.969 57.543 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
341.858 224.633 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
399.402 219.969 164.693 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
401.102 224.633 Td
( Valores de referencia ) Tj
ET
1 1 1 rg
31.465 190.772 221.102 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 207.642 Td
( Actividad de Protrombina) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 197.521 Td
(Índice de Quick) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
89.008 195.736 Td
( ) Tj
ET
1 1 1 rg
254.268 190.772 84.189 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 207.642 Td
( 83 ) Tj
ET
1 1 1 rg
340.157 190.772 57.543 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 207.642 Td
( % ) Tj
ET
1 1 1 rg
399.402 190.772 164.693 27.496 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 209.427 Td
(80 - 120) Tj
ET
1 1 1 rg
31.465 173.48 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 178.445 Td
( INR ) Tj
ET
1 1 1 rg
254.268 173.48 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
310.961 178.445 Td
( 1.12 ) Tj
ET
1 1 1 rg
340.157 173.48 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 178.445 Td
(  ) Tj
ET
1 1 1 rg
399.402 173.48 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 180.23 Td
(0.9 - 1.1) Tj
ET
q
198.709 0 0 85.039 0.283 756.567 cm
/Im0 Do
Q
q
204.378 0 0 50.457 193.89 0.283 cm
/Im1 Do
Q
endstream
endobj
19 0 obj
<<
/Type/Page
/Parent 2 0 R
/MediaBox[ 0 0 595.276 841.89 ]
/Contents 18 0 R
>>
endobj
20 0 obj
<<
/Length 11227
>>
stream
1 1 1 rg
380.976 737.575 182.835 38.268 re f
BT
/F0 10 Tf
0 0 0 rg
382.11 765.784 Td
(Paciente: ) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
426.614 765.484 Td
(Dña. MARIA BELIO BERGUA) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
382.11 753.878 Td
(Análisis: 4580   - 11/Jun/2019 -) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
382.11 743.758 Td
(Página ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
409.606 743.758 Td
(3 de ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
427.748 743.758 Td
(5) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
29.764 703.121 Td
(Estudio Vía Intrínseca) Tj
ET
0.867 0.867 0.867 rg
31.465 671.244 221.102 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 675.909 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
254.268 671.244 84.189 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
282.331 675.909 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
340.157 671.244 57.543 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
341.858 675.909 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
399.402 671.244 164.693 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
401.102 675.909 Td
( Valores de referencia ) Tj
ET
1 1 1 rg
31.465 653.953 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 658.918 Td
( Tiempo de Tromboplastina Parcial Activada ) Tj
ET
1 1 1 rg
254.268 653.953 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 658.918 Td
( 31 ) Tj
ET
1 1 1 rg
340.157 653.953 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 658.918 Td
( segundos ) Tj
ET
1 1 1 rg
399.402 653.953 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 660.703 Td
(20 - 39) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
29.764 643.31 Td
(Estudio Vía Final Común) Tj
ET
0.867 0.867 0.867 rg
31.465 611.433 221.102 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 616.098 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
254.268 611.433 84.189 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
282.331 616.098 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
340.157 611.433 57.543 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
341.858 616.098 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
399.402 611.433 164.693 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
401.102 616.098 Td
( Valores de referencia ) Tj
ET
1 1 1 rg
31.465 582.236 221.102 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 599.106 Td
( Fibrinógeno) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 588.986 Td
(Funcional-Coagulométrico) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
127.559 587.201 Td
( ) Tj
ET
1 1 1 rg
254.268 582.236 84.189 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
313.795 599.106 Td
( 251 ) Tj
ET
1 1 1 rg
340.157 582.236 57.543 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 599.106 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 582.236 164.693 27.496 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 600.891 Td
(250 - 450) Tj
ET
1 1 1 rg
31.465 553.039 221.102 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 569.91 Td
( Antitrombina III) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 559.789 Td
(Actividad-Sustrato cromogénico) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
147.118 558.004 Td
( ) Tj
ET
1 1 1 rg
254.268 553.039 84.189 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
313.795 569.91 Td
( 105 ) Tj
ET
1 1 1 rg
340.157 553.039 57.543 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 569.91 Td
( % ) Tj
ET
1 1 1 rg
399.402 553.039 164.693 27.496 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 571.695 Td
(80 - 120) Tj
ET
BT
/F1 12 Tf
0 0 0 rg
29.764 540.552 Td
(BIOQUIMICA) Tj
ET
0.867 0.867 0.867 rg
31.465 507.969 221.102 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 512.633 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
254.268 507.969 84.189 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
282.331 512.633 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
340.157 507.969 57.543 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
341.858 512.633 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
399.402 507.969 164.693 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
401.102 512.633 Td
( Valores de referencia ) Tj
ET
1 1 1 rg
31.465 472.819 221.102 33.449 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 495.642 Td
( Glucosa basal ) Tj
ET
1 1 1 rg
254.268 472.819 84.189 33.449 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 495.642 Td
( 74 ) Tj
ET
1 1 1 rg
340.157 472.819 57.543 33.449 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 495.642 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 472.819 164.693 33.449 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 497.427 Td
(60 - 110) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 487.506 Td
(Sup. 100 "Disglucemia de ayuno"\(ADA) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 477.584 Td
(2010\)) Tj
ET
1 1 1 rg
31.465 455.528 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 460.492 Td
( Colesterol ) Tj
ET
1 1 1 rg
254.268 455.528 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
313.795 460.492 Td
( 180 ) Tj
ET
1 1 1 rg
340.157 455.528 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 460.492 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 455.528 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 462.277 Td
(Inf. 200) Tj
ET
1 1 1 rg
31.465 438.236 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 443.201 Td
( HDL-Colesterol ) Tj
ET
1 1 1 rg
254.268 438.236 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 443.201 Td
( 70 ) Tj
ET
1 1 1 rg
340.157 438.236 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 443.201 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 438.236 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 444.986 Td
(Sup. 40) Tj
ET
1 1 1 rg
31.465 413.008 221.102 23.528 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 425.91 Td
( LDL-Colesterol ) Tj
ET
1 1 1 rg
254.268 413.008 84.189 23.528 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 425.91 Td
( 98 ) Tj
ET
1 1 1 rg
340.157 413.008 57.543 23.528 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 425.91 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 413.008 164.693 23.528 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 427.695 Td
(Inf. 130 Prevención primaria) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 417.773 Td
(Inf. 100 Prevención secundaria) Tj
ET
1 1 1 rg
31.465 395.717 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 400.681 Td
( Colesterol VLDL ) Tj
ET
1 1 1 rg
254.268 395.717 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 400.681 Td
( 12 ) Tj
ET
1 1 1 rg
340.157 395.717 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 400.681 Td
( mg/dl ) Tj
ET
1 1 1 rg
399.402 395.717 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 402.466 Td
(Inf. 32) Tj
ET
1 1 1 rg
31.465 370.488 221.102 23.528 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 383.39 Td
( Triglicéridos ) Tj
ET
1 1 1 rg
254.268 370.488 84.189 23.528 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 383.39 Td
( 58 ) Tj
ET
1 1 1 rg
340.157 370.488 57.543 23.528 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 383.39 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 370.488 164.693 23.528 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 385.175 Td
(Inf. 150 Tras ayuno de 8-10 horas) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 375.254 Td
(Inf. 175 Sin ayuno de 8-10 horas) Tj
ET
1 1 1 rg
31.465 353.197 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 358.162 Td
( Ácido Úrico ) Tj
ET
1 1 1 rg
254.268 353.197 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
316.63 358.162 Td
( 4.8 ) Tj
ET
1 1 1 rg
340.157 353.197 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 358.162 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 353.197 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 359.947 Td
(2.6 - 6.0) Tj
ET
1 1 1 rg
31.465 351.78 532.63 -0.283 re f
1 1 1 rg
31.465 335.906 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 340.87 Td
( Urea ) Tj
ET
1 1 1 rg
254.268 335.906 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 340.87 Td
( 33 ) Tj
ET
1 1 1 rg
340.157 335.906 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 340.87 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 335.906 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 342.655 Td
(13 - 45) Tj
ET
1 1 1 rg
31.465 318.614 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 323.579 Td
( Creatinina ) Tj
ET
1 1 1 rg
254.268 318.614 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
310.961 323.579 Td
( 0.61 ) Tj
ET
1 1 1 rg
340.157 318.614 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 323.579 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 318.614 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 325.364 Td
(0.55 - 1.02) Tj
ET
1 1 1 rg
31.465 301.323 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 306.288 Td
( Bilirrubina total ) Tj
ET
1 1 1 rg
254.268 301.323 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
316.63 306.288 Td
( 0.8 ) Tj
ET
1 1 1 rg
340.157 301.323 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 306.288 Td
( mg/dL ) Tj
ET
1 1 1 rg
399.402 301.323 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 308.073 Td
(0.2 - 1.2) Tj
ET
1 1 1 rg
31.465 284.031 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 288.996 Td
( Hierro ) Tj
ET
1 1 1 rg
254.268 284.031 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 288.996 Td
( 76 ) Tj
ET
1 1 1 rg
340.157 284.031 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 288.996 Td
( µg/dL ) Tj
ET
1 1 1 rg
399.402 284.031 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 290.781 Td
(37 - 160) Tj
ET
1 1 1 rg
31.465 254.835 221.102 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 271.705 Td
( Ferritina) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 261.584 Td
(Técnica ICMA) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
83.622 259.799 Td
( ) Tj
ET
1 1 1 rg
254.268 254.835 84.189 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
305.575 271.705 Td
( 29.83 ) Tj
ET
1 1 1 rg
340.157 254.835 57.543 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 271.705 Td
( ng/mL ) Tj
ET
1 1 1 rg
399.402 254.835 164.693 27.496 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 273.49 Td
(10 - 130) Tj
ET
BT
/F1 12 Tf
0 0 0 rg
29.764 242.347 Td
(ENZIMAS) Tj
ET
0.867 0.867 0.867 rg
31.465 209.764 221.102 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 214.429 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
254.268 209.764 84.189 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
282.331 214.429 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
340.157 209.764 57.543 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
341.858 214.429 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
399.402 209.764 164.693 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
401.102 214.429 Td
( Valores de referencia ) Tj
ET
1 1 1 rg
31.465 192.472 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 197.437 Td
( GOT - AST - ) Tj
ET
1 1 1 rg
254.268 192.472 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 197.437 Td
( 15 ) Tj
ET
1 1 1 rg
340.157 192.472 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 197.437 Td
( U/L ) Tj
ET
1 1 1 rg
399.402 192.472 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 199.222 Td
(8 - 43) Tj
ET
1 1 1 rg
31.465 175.181 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 180.146 Td
( GPT - ALT- ) Tj
ET
1 1 1 rg
254.268 175.181 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
324.85 180.146 Td
( 9 ) Tj
ET
1 1 1 rg
340.157 175.181 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 180.146 Td
( U/L ) Tj
ET
1 1 1 rg
399.402 175.181 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 181.931 Td
(7 - 45) Tj
ET
1 1 1 rg
31.465 157.89 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 162.855 Td
( Fosfatasa Alcalina ) Tj
ET
1 1 1 rg
254.268 157.89 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 162.855 Td
( 51 ) Tj
ET
1 1 1 rg
340.157 157.89 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 162.855 Td
( U/L ) Tj
ET
1 1 1 rg
399.402 157.89 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 164.64 Td
(38 - 126) Tj
ET
1 1 1 rg
31.465 140.598 221.102 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 145.563 Td
( GGT - Gamma glutamil transpeptidasa -  ) Tj
ET
1 1 1 rg
254.268 140.598 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
319.465 145.563 Td
( 10 ) Tj
ET
1 1 1 rg
340.157 140.598 57.543 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 145.563 Td
( U/L ) Tj
ET
1 1 1 rg
399.402 140.598 164.693 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 147.348 Td
(9 - 36) Tj
ET
q
198.709 0 0 85.039 0.283 756.567 cm
/Im0 Do
Q
q
204.378 0 0 50.457 193.89 0.283 cm
/Im1 Do
Q
endstream
endobj
21 0 obj
<<
/Type/Page
/Parent 2 0 R
/MediaBox[ 0 0 595.276 841.89 ]
/Contents 20 0 R
>>
endobj
22 0 obj
<<
/Length 4208
>>
stream
1 1 1 rg
380.976 737.575 182.835 38.268 re f
BT
/F0 10 Tf
0 0 0 rg
382.11 765.784 Td
(Paciente: ) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
426.614 765.484 Td
(Dña. MARIA BELIO BERGUA) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
382.11 753.878 Td
(Análisis: 4580   - 11/Jun/2019 -) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
382.11 743.758 Td
(Página ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
409.606 743.758 Td
(4 de ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
427.748 743.758 Td
(5) Tj
ET
BT
/F1 12 Tf
0 0 0 rg
29.764 701.276 Td
(HORMONAS) Tj
ET
0.867 0.867 0.867 rg
31.465 668.693 221.102 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 673.358 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
254.268 668.693 84.189 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
282.331 673.358 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
340.157 668.693 57.543 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
341.858 673.358 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
399.402 668.693 164.693 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
401.102 673.358 Td
( Valores de referencia ) Tj
ET
1 1 1 rg
31.465 639.496 221.102 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 656.366 Td
( T3 total) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 646.246 Td
(Triyodotironina total-Técnica ICMA) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
157.323 644.461 Td
( ) Tj
ET
1 1 1 rg
254.268 639.496 84.189 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
310.961 656.366 Td
( 0.87 ) Tj
ET
1 1 1 rg
340.157 639.496 57.543 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 656.366 Td
( ng/mL ) Tj
ET
1 1 1 rg
399.402 639.496 164.693 27.496 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 658.151 Td
(0.64 - 1.52) Tj
ET
1 1 1 rg
31.465 610.299 221.102 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 627.169 Td
( T4) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 617.049 Td
(Tiroxina Total-Técnica ICMA) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
135.213 615.264 Td
( ) Tj
ET
1 1 1 rg
254.268 610.299 84.189 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
310.961 627.169 Td
( 5.13 ) Tj
ET
1 1 1 rg
340.157 610.299 57.543 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 627.169 Td
( µg/dL ) Tj
ET
1 1 1 rg
399.402 610.299 164.693 27.496 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 628.954 Td
(4.5 - 12.5) Tj
ET
1 1 1 rg
31.465 565.228 221.102 43.37 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 597.973 Td
( TSH) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 587.852 Td
(Hormona Tiroestimulante-Técnica ICMA) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
176.882 586.067 Td
( ) Tj
ET
1 1 1 rg
254.268 565.228 84.189 43.37 re f
BT
/F0 10 Tf
0 0 0 rg
310.961 597.973 Td
( 2.64 ) Tj
ET
1 1 1 rg
340.157 565.228 57.543 43.37 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 597.973 Td
( µU/mL ) Tj
ET
1 1 1 rg
399.402 565.228 164.693 43.37 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 599.758 Td
(0.4 - 3.7) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 589.836 Td
(0.1 - 2.5 Embarazo primer trimestre) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 579.915 Td
(0.2 - 3.0 Embarazo segundo trimestre) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 569.994 Td
(0.3 - 3.0 Embarazo tercer trimestre) Tj
ET
BT
/F1 12 Tf
0 0 0 rg
29.764 552.741 Td
(VITAMINAS) Tj
ET
0.867 0.867 0.867 rg
31.465 520.157 221.102 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 524.822 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
254.268 520.157 84.189 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
282.331 524.822 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
340.157 520.157 57.543 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
341.858 524.822 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
399.402 520.157 164.693 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
401.102 524.822 Td
( Valores de referencia ) Tj
ET
1 1 1 rg
31.465 475.087 221.102 43.37 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 507.831 Td
( Vitamina D3) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 497.71 Td
(25- Hidroxi Colecalciferol-Técnica ICMA) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
176.315 495.925 Td
( ) Tj
ET
1 1 1 rg
254.268 475.087 84.189 43.37 re f
BT
/F0 10 Tf
0 0 0 rg
305.575 507.831 Td
( 17.90 ) Tj
ET
1 1 1 rg
340.157 475.087 57.543 43.37 re f
BT
/F0 10 Tf
0 0 0 rg
341.858 507.831 Td
( ng/mL ) Tj
ET
1 1 1 rg
399.402 475.087 164.693 43.37 re f
BT
/F0 8 Tf
0 0 0 rg
401.102 509.616 Td
(Inf. 10 Déficit) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 499.695 Td
(10 - 30 Déficit moderado) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 489.773 Td
(30 - 96 Valores recomendados) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.102 479.852 Td
(Sup. 96 Exceso) Tj
ET
q
198.709 0 0 85.039 0.283 756.567 cm
/Im0 Do
Q
q
204.378 0 0 50.457 193.89 0.283 cm
/Im1 Do
Q
endstream
endobj
23 0 obj
<<
/Type/Page
/Parent 2 0 R
/MediaBox[ 0 0 595.276 841.89 ]
/Contents 22 0 R
>>
endobj
24 0 obj
<<
/Length 8592
>>
stream
1 1 1 rg
380.976 737.575 182.835 38.268 re f
BT
/F0 10 Tf
0 0 0 rg
382.11 765.784 Td
(Paciente: ) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
426.614 765.484 Td
(Dña. MARIA BELIO BERGUA) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
382.11 753.878 Td
(Análisis: 4580   - 11/Jun/2019 -) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
382.11 743.758 Td
(Página ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
409.606 743.758 Td
(5 de ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
427.748 743.758 Td
(5) Tj
ET
BT
/F1 14 Tf
0 0 0 rg
228.472 699.431 Td
(ANALISIS DE ORINA) Tj
ET
BT
/F1 12 Tf
0 0 0 rg
29.764 672.363 Td
(ORINA) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
29.764 647.846 Td
(SISTEMATICO DE ORINA) Tj
ET
0.867 0.867 0.867 rg
31.465 604.063 105.732 27.496 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 614.681 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
138.898 604.063 111.118 27.496 re f
BT
/F1 10 Tf
0 0 0 rg
193.89 614.681 Td
( Resultado ) Tj
ET
0.867 0.867 0.867 rg
251.717 604.063 68.031 27.496 re f
BT
/F1 10 Tf
0 0 0 rg
253.417 614.681 Td
( Unidades ) Tj
ET
0.867 0.867 0.867 rg
321.449 604.063 84.189 27.496 re f
BT
/F1 10 Tf
0 0 0 rg
323.15 620.633 Td
( Valores de) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
323.15 608.728 Td
(referencia ) Tj
ET
1 1 1 rg
31.465 586.772 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 591.736 Td
( pH ) Tj
ET
1 1 1 rg
138.898 586.772 111.118 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
228.189 591.736 Td
( 6.5 ) Tj
ET
1 1 1 rg
251.717 586.772 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 591.736 Td
(  ) Tj
ET
1 1 1 rg
321.449 586.772 84.189 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
323.15 593.521 Td
(4.5 - 7.5) Tj
ET
1 1 1 rg
31.465 569.48 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 574.445 Td
( Densidad ) Tj
ET
1 1 1 rg
138.898 569.48 111.118 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
217.134 574.445 Td
( 1.028 ) Tj
ET
1 1 1 rg
251.717 569.48 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 574.445 Td
(  ) Tj
ET
1 1 1 rg
321.449 569.48 84.189 15.591 re f
BT
/F0 8 Tf
0 0 0 rg
323.15 576.23 Td
(1.000 - 1.040) Tj
ET
1 1 1 rg
31.465 552.189 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 557.154 Td
( Proteínas ) Tj
ET
1 1 1 rg
138.898 552.189 111.118 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
202.677 557.154 Td
( Negativo ) Tj
ET
1 1 1 rg
251.717 552.189 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 557.154 Td
(  ) Tj
ET
1 1 1 rg
321.449 552.189 84.189 15.591 re f
1 1 1 rg
31.465 534.898 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 539.862 Td
( Glucosa ) Tj
ET
1 1 1 rg
138.898 534.898 111.118 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
202.677 539.862 Td
( Negativo ) Tj
ET
1 1 1 rg
251.717 534.898 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 539.862 Td
(  ) Tj
ET
1 1 1 rg
321.449 534.898 84.189 15.591 re f
1 1 1 rg
31.465 517.606 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 522.571 Td
( Cuerpos cetónicos ) Tj
ET
1 1 1 rg
138.898 517.606 111.118 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
202.677 522.571 Td
( Negativo ) Tj
ET
1 1 1 rg
251.717 517.606 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 522.571 Td
(  ) Tj
ET
1 1 1 rg
321.449 517.606 84.189 15.591 re f
1 1 1 rg
31.465 500.315 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 505.28 Td
( Bilirrubina ) Tj
ET
1 1 1 rg
138.898 500.315 111.118 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
202.677 505.28 Td
( Negativo ) Tj
ET
1 1 1 rg
251.717 500.315 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 505.28 Td
(  ) Tj
ET
1 1 1 rg
321.449 500.315 84.189 15.591 re f
1 1 1 rg
31.465 471.118 105.732 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 487.988 Td
( Hemoglobina /) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
33.165 476.083 Td
(Mioglobina ) Tj
ET
1 1 1 rg
138.898 471.118 111.118 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
202.677 487.988 Td
( Negativo ) Tj
ET
1 1 1 rg
251.717 471.118 68.031 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 487.988 Td
(  ) Tj
ET
1 1 1 rg
321.449 471.118 84.189 27.496 re f
1 1 1 rg
31.465 453.827 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 458.792 Td
( Nitritos ) Tj
ET
1 1 1 rg
138.898 453.827 111.118 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
202.677 458.792 Td
( Negativo ) Tj
ET
1 1 1 rg
251.717 453.827 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 458.792 Td
(  ) Tj
ET
1 1 1 rg
321.449 453.827 84.189 15.591 re f
1 1 1 rg
31.465 436.535 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 441.5 Td
( Urobilinógeno ) Tj
ET
1 1 1 rg
138.898 436.535 111.118 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
202.677 441.5 Td
( Negativo ) Tj
ET
1 1 1 rg
251.717 436.535 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 441.5 Td
(  ) Tj
ET
1 1 1 rg
321.449 436.535 84.189 15.591 re f
1 1 1 rg
31.465 407.339 105.732 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 424.209 Td
( Leucocitos) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 414.088 Td
(Esterasa leucocitaria) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
108.283 412.303 Td
( ) Tj
ET
1 1 1 rg
138.898 407.339 111.118 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
206.929 424.209 Td
( Positivo ) Tj
ET
1 1 1 rg
251.717 407.339 68.031 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 424.209 Td
(  ) Tj
ET
1 1 1 rg
321.449 407.339 84.189 27.496 re f
1 1 1 rg
31.465 390.047 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 395.012 Td
( ) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
36 394.712 Td
(SEDIMENTO:) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
98.646 395.012 Td
( ) Tj
ET
1 1 1 rg
31.465 372.756 105.732 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 377.721 Td
( Bacterias ) Tj
ET
1 1 1 rg
138.898 372.756 111.118 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
144.283 377.721 Td
( Bacteriuria abundante ) Tj
ET
1 1 1 rg
251.717 372.756 68.031 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
311.811 377.721 Td
(  ) Tj
ET
1 1 1 rg
321.449 372.756 84.189 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
397.701 377.721 Td
(  ) Tj
ET
1 1 1 rg
407.339 372.756 162.142 15.591 re f
1 1 1 rg
31.465 343.559 105.732 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 360.429 Td
( Células Epiteliales) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 350.309 Td
(Citometría de Flujo) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
101.48 348.524 Td
( ) Tj
ET
1 1 1 rg
138.898 343.559 111.118 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
231.024 360.429 Td
( 13 ) Tj
ET
1 1 1 rg
251.717 343.559 68.031 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 360.429 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
256.252 362.214 Td
( /campo ) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
287.433 360.429 Td
( ) Tj
ET
1 1 1 rg
321.449 343.559 84.189 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
323.15 360.429 Td
( ) Tj
ET
1 1 1 rg
31.465 314.362 105.732 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 331.232 Td
( Hematíes) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 321.112 Td
(Citometría de Flujo) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
101.48 319.327 Td
( ) Tj
ET
1 1 1 rg
138.898 314.362 111.118 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
236.409 331.232 Td
( 2 ) Tj
ET
1 1 1 rg
251.717 314.362 68.031 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 331.232 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
256.252 333.017 Td
( /campo ) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
287.433 331.232 Td
( ) Tj
ET
1 1 1 rg
321.449 314.362 84.189 27.496 re f
1 1 1 rg
31.465 285.165 105.732 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 302.036 Td
( Leucocitos) Tj
ET
BT
/F2 8 Tf
0 0 0 rg
33.165 291.915 Td
(Citometría de Flujo) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
101.48 290.13 Td
( ) Tj
ET
1 1 1 rg
138.898 285.165 111.118 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
231.024 302.036 Td
( 31 ) Tj
ET
1 1 1 rg
251.717 285.165 68.031 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
253.417 302.036 Td
( ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
256.252 303.821 Td
( /campo ) Tj
ET
BT
/F0 10 Tf
0 0 0 rg
287.433 302.036 Td
( ) Tj
ET
1 1 1 rg
321.449 285.165 84.189 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
400.535 302.036 Td
( ) Tj
ET
1 1 1 rg
407.339 285.165 57.543 27.496 re f
BT
/F0 10 Tf
0 0 0 rg
409.039 302.036 Td
( ) Tj
ET
1 1 1 rg
466.583 285.165 97.512 27.496 re f
BT
/F1 14 Tf
0 0 0 rg
239.528 270.833 Td
(MICROBIOLOGIA) Tj
ET
BT
/F1 12 Tf
0 0 0 rg
278.079 243.765 Td
(ORINA) Tj
ET
BT
/F1 10 Tf
0 0 0 rg
29.764 219.247 Td
(ESTUDIO BACTERIOLÓGICO) Tj
ET
0.867 0.867 0.867 rg
31.465 187.37 164.693 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
33.165 192.035 Td
( Determinación ) Tj
ET
0.867 0.867 0.867 rg
197.858 187.37 366.236 15.591 re f
BT
/F1 10 Tf
0 0 0 rg
199.559 192.035 Td
( Resultado ) Tj
ET
1 1 1 rg
31.465 170.079 164.693 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
33.165 175.044 Td
( Flora aislada ) Tj
ET
1 1 1 rg
197.858 170.079 366.236 15.591 re f
BT
/F0 10 Tf
0 0 0 rg
199.559 175.044 Td
( Sin crecimiento bacteriano. ) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
401.386 120.703 Td
(Validado facultativo de Laboratorio:MLG , PA) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
452.976 110.781 Td
(Firmado electrónicamente por:) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
465.165 100.86 Td
(Dir.Técnico: R.Goya Ramos) Tj
ET
BT
/F0 8 Tf
0 0 0 rg
411.591 90.939 Td
(DR.GOYA ANÁLISIS S.L.-CIF:B-82686478) Tj
ET
q
198.709 0 0 85.039 0.283 756.567 cm
/Im0 Do
Q
q
204.378 0 0 50.457 193.89 0.283 cm
/Im1 Do
Q
endstream
endobj
25 0 obj
<<
/Type/Page
/Parent 2 0 R
/MediaBox[ 0 0 595.276 841.89 ]
/Contents 24 0 R
>>
endobj
26 0 obj
<<
/Type/Catalog
/Pages 2 0 R
>>
endobj
2 0 obj
<<
/Type/Pages
/Kids[
14 0 R
19 0 R
21 0 R
23 0 R
25 0 R
]
/Count 5
/Resources 3 0 R
>>
endobj
3 0 obj
<<
/ProcSet[/PDF/Text/ImageC]
/Font<<
/F0 7 0 R
/F1 10 0 R
/F2 17 0 R
>>
/XObject <<
/Im0 12 0 R
/Im1 13 0 R
 >>
>>
endobj
xref
0 27
0000000000 65535 f
0000000009 00000 n
0000089727 00000 n
0000089830 00000 n
0000000000 00000 n
0000000118 00000 n
0000001048 00000 n
0000001191 00000 n
0000001356 00000 n
0000002286 00000 n
0000002429 00000 n
0000002600 00000 n
0000003794 00000 n
0000024012 00000 n
0000051170 00000 n
0000051266 00000 n
0000052197 00000 n
0000052343 00000 n
0000052518 00000 n
0000065110 00000 n
0000065206 00000 n
0000076486 00000 n
0000076582 00000 n
0000080842 00000 n
0000080938 00000 n
0000089582 00000 n
0000089678 00000 n
trailer
<<
/Size 27
/Root 26 0 R
/Info 1 0 R
/ID[(436304284bdDd)(436304284bdDd)]
>>
startxref
89961
%%EOF
27 0 obj
<<
/Fields [ 28 0 R ]
/SigFlags 3
>>
endobj
26 0 obj
<<
/Type /Catalog
/Pages 2 0 R
/AcroForm 27 0 R
>>
endobj
28 0 obj
<<
/T (First Name)
/Type /Annot
/Subtype /Widget
/FT /Sig
/F 4
/Rect [ 0 0 0 0 ]
/P 14 0 R
/V 29 0 R
>>
endobj
14 0 obj
<<
/Type /Page
/Parent 2 0 R
/MediaBox [ 0 0 595.276 841.89 ]
/Contents 11 0 R
/Annots [ 28 0 R ]
>>
endobj
29 0 obj
<<
/Type /Sig
/Filter /Adobe.PPKLite
/SubFilter /adbe.pkcs7.sha1
/Contents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
/ByteRange [ 0 91058 95944 579                                                                                                                                                                                          
]
/M (D:20190614101653+02'00')
/Reason ()
/Location ()
/ContactInfo ()
>>
endobj
xref
0 1
0000000000 65535 f 
14 1
0000090857 00000 n 
26 4
0000090670 00000 n 
0000090617 00000 n 
0000090737 00000 n 
0000090974 00000 n 
trailer
<<
/Root 26 0 R
/Info 1 0 R
/ID [ (436304284bdDd) <6D8D8A6B5AE6A1F6EA3F8619D39B2252> ]
/Size 30
/Prev 89961
>>
startxref
96243
%%EOF
